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Description
[0001] The present invention relates to a polynucleotide from Emiliana huxleyi which codes for a desaturase and which
can be employed for the recombinant production of polyunsaturated fatty acids. The invention furthermore relates to
vectors, host cells and transgenic nonhuman organisms which comprise the polynucleotides according to the invention,
and to the polypeptides encoded by the polynucleotides. The invention furthermore relates to antibodies against the
polypeptides according to the invention. Finally, the invention also relates to production methods for the polyunsaturated
fatty acids and for oil, lipid and fatty acid compositions and to their use as drugs, cosmetics, foodstuffs, feedstuffs,
preferably fish food, or food supplements.
[0002] Fatty acids and triacylglycerides have a multiplicity of applications in the food industry, in animal nutrition, in
cosmetics and in the pharmacological sector. Depending on whether they are free saturated or unsaturated fatty acids
or else triacylglycerides with an elevated content of saturated or unsaturated fatty acids, they are suitable for very different
applications. Polyunsaturated fatty acids such as linoleic acid and linolenic acid are essential for mammals, since they
cannot be produced by the latter themselves. Polyunsaturated ω3-fatty acids and ω6-fatty acids are therefore an important
constituent in animal and human nutrition.
[0003] Polyunsaturated long-chain ω3-fatty acids such as eicosapentaenoic acid (= EPA, C20:5Δ5,8,11,14,17) or do-
cosahexaenoic acid (= DHA, C22:6Δ4,7,10,13,16,19) are important components in human nutrition owing to their various
roles in health aspects, including the development of the child brain, the functionality of the eyes, the synthesis of
hormones and other signal substances, and the prevention of cardiovascular disorders, cancer and diabetes (Poulos,
A Lipids 30:1-14, 1995; Horrocks, LA and Yeo YK Pharmacol Res 40:211-225, 1999). This is why there is a demand for
the production of polyunsaturated long-chain fatty acids.
[0004] Owing to the present-day composition of human food, an addition of polyunsaturated ω3-fatty acids, which are
preferentially found in fish oils, to the food is particularly important. Thus, for example, polyunsaturated fatty acids such
as docosahexaenoic acid (= DHA, C22:6Δ4,7,10,13,16,19) or eicosapentaenoic acid (= EPA, C20:5Δ5,8,11,14,17) are added
to infant formula to improve the nutritional value. The unsaturated fatty acid DHA is said to have a positive effect on the
development and maintenance of brain functions.
[0005] Hereinbelow, polyunsaturated fatty acids are referred to as PUFA, PUFAs, LCPUFA or LCPUFAs (polyunsat-
urated fatty acids, PUFA, long-chain polyunsaturated fatty acids, LCPUFA).
[0006] The various fatty acids and triglycerides are mainly obtained from microorganisms such as Mortierella and
Schizochytrium or from oil-producing plants such as soybean, oilseed rape, algae such as Crypthecodinium or Phaeo-
dactylum and others, where they are obtained, as a rule, in the form of their triacylglycerides (= triglycerides = triglycerols).
However, they can also be obtained from animals, such as, for example, fish. The free fatty acids are advantageously
prepared by hydrolysis. Very long-chain polyunsaturated fatty acids such as DHA, EPA, arachidonic acid (= ARA,
C20:4Δ5,8,11,14), dihomo-γ-linolenic acid (C20:3Δ8,11,14) or docosapentaenoic acid (DPA, C22:5Δ7,10,13,16,19) are not syn-
thesized in oil crops such as oilseed rape, soybean, sunflower or safflower. Conventional natural sources of these fatty
acids are fish such as herring, salmon, sardine, redfish, eel, carp, trout, halibut, mackerel, zander or tuna, or algae.
[0007] Depending on the intended use, oils with saturated or unsaturated fatty acids are preferred. In human nutrition,
for example, lipids with unsaturated fatty acids, specifically polyunsaturated fatty acids, are preferred. The polyunsatu-
rated ω3-fatty acids are said to have a positive effect on the cholesterol level in the blood and thus on the possibility of
preventing heart disease. The risk of heart disease, a stroke or hypertension can be reduced markedly by adding these
ω3-fatty acids to food. Also, ω3-fatty acids have a positive effect on inflammatory, specifically on chronically inflammatory,
methods in association with immunological diseases such as rheumatoid arthritis. They are therefore added to foodstuffs,
specifically to dietetic foodstuffs, or are employed in medicaments. ω6-Fatty acids such as arachidonic acid tend to have
a negative effect on these disorders in connection with these rheumatic diseases on account of our usual dietary intake.
[0008] ω3- and ω6-fatty acids are precursors of tissue hormones, known as eicosanoids, such as the prostaglandins,
which are derived from dihomo-γ-linolenic acid, arachidonic acid and eicosapentaenoic acid, and of the thromboxanes
and leukotrienes, which are derived from arachidonic acid and eicosapentaenoic acid. Eicosanoids (known as the PG2
series) which are formed from ω6-fatty acids generally promote inflammatory reactions, while eicosanoids (known as
the PG3 series) from ω3-fatty acids have little or no proinflammatory effect.
[0009] Owing to the positive characteristics of the polyunsaturated fatty acids, there has been no lack of attempts in
the past to make available genes which are involved in the synthesis of fatty acids or triglycerides for the production of
oils in various organisms with a modified content of unsaturated fatty acids. Thus, WO 91/13972 and its US equivalent
describe a Δ9-desaturase. WO 93/11245 claims a Δ15-desaturase and WO 94/11516 a Δ12-desaturase. Further desat-
urases are described, for example, in EP-A-0 550 162, WO 94/18337, WO 97/30582, WO 97/21340, WO 95/18222, EP-
A-0 794 250, Stukey et al., J. Biol. Chem., 265, 1990: 20144-20149, Wada et al., Nature 347, 1990: 200-203 or Huang
et al., Lipids 34, 1999: 649-659. However, the biochemical characterization of the various desaturases has been insuf-
ficient to date since the enzymes, being membrane-bound proteins, present great difficulty in their isolation and char-
acterization (McKeon et al., Methods in Enzymol. 71, 1981: 12141-12147, Wang et al., Plant Physiol. Biochem., 26,
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1988: 777-792). As a rule, membrane-bound desaturases are characterized by being introduced into a suitable organism
which is subsequently analyzed for enzyme activity by analyzing the starting materials and the products. Δ6-Desaturases
are described in WO 93/06712, US 5,614,393, WO 96/21022, WO 00/21557 and WO 99/27111. Their application for
production in transgenic organisms is described, for example, in WO 98/46763, WO 98/46764 and WO 98/46765. In
this context, the expression of various desaturases and the formation of polyunsaturated fatty acids is also described
and claimed; see, for example, WO 99/64616 or WO 98/46776. As regards the expression efficacy of desaturases and
its effect on the formation of polyunsaturated fatty acids, it must be noted that the expression of a single desaturase as
described to date has only resulted in low contents of unsaturated fatty acids/lipids such as, for example, γ-linolenic acid
and stearidonic acid. Moreover, a mixture of ω3- and ω6-fatty acids was obtained, as a rule.
[0010] Especially suitable microorganisms for the production of PUFAs are microalgae such as Phaeodactylum tri-
cornutum, Porphiridium species, Thraustochytrium species, Schizochytrium species or Crypthecodinium species, ciliates
such as Stylonychia or Colpidium, fungae such as Mortierella, Entomophthora or Mucor and/or mosses such as Phys-
comitrella, Ceratodon and Marchantia (R. Vazhappilly & F. Chen (1998) Botanica Marina 41: 553-558; K. Totani & K.
Oba (1987) Lipids 22: 1060-1062; M. Akimoto et al. (1998) Appl. Biochemistry and Biotechnology 73: 269-278). Strain
selection has resulted in the development of a number of mutant strains of the microorganisms in question which produce
a series of desirable compounds including PUFAs. However, the mutation and selection of strains with an improved
production of a particular molecule such as the polyunsaturated fatty acids is a time-consuming and difficult method.
This is why recombinant methods as described above are preferred whenever possible. However, only limited amounts
of the desired polyunsaturated fatty acids such as DPA, EPA or ARA can be produced with the aid of the abovementioned
microorganisms. Moreover, depending on the microorganism used, these are generally generated as fatty acid mixtures
of, for example, EPA, DPA and ARA.
[0011] A variety of synthetic pathways is being discussed for the synthesis of arachidonic acid, eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA). Thus, EPA or DHA are produced in marine bacteria such as Vibrio sp. or
Shewanella sp. via the polyketide pathway (Yu, R. et al. Lipids 35:1061-1064, 2000; Takeyama, H. et al. Microbiology
143:2725-2731, 1997).
[0012] An alternative strategy is the alternating activity of desaturases and elongases (Zank, T.K. et al. Plant Journal
31:255-268, 2002; Sakuradani, E. et al. Gene 238:445-453, 1999). A modification of this pathway via Δ6-desaturase,
Δ6-elongase, Δ5-desaturase, Δ5-elongase and Δ4-desaturase is the Sprecher pathway (Sprecher 2000, Biochim. Bio-
phys. Acta 1486:219-231) in mammals. Instead of the Δ4-desaturation, a further elongation step is effected here to give
C24, followed by a further Δ6-desaturation and finally β-oxidation to give the C22 chain length. What is known as the
Sprecher pathway is, however, not suitable for the production in plants and microorganisms since the regulatory mech-
anisms are not yet known.
[0013] Depending on their desaturation pattern, the polyunsaturated fatty acids can be divided into two large classes,
viz. ω6- or ω3-fatty acids, which differ with regard to their metabolic and functional activities. The starting material for
the ω6-metabolic pathway is the fatty acid linoleic acid (18:2Δ9,12) while the Δ3-pathway proceeds via linolenic acid
(18:3Δ9,12,15). Linolenic acid is formed by the activity of a Δ15-desaturases (Tocher et al. 1998, Prog. Lipid Res. 37,
73-117; Domergue et al. 2002, Eur. J. Biochem. 269, 4105-4113).
[0014] Mammals, and thus also humans, have no corresponding desaturase activity (Δ12- and Δ15-desaturase) and
must take up these fatty acids (essential fatty acids) via food. Starting with these precursors, the physiologically important
polyunsaturated fatty acids arachidonic acid (= ARA, 20:4Δ5,8,11,14), an ω6-fatty acid and the two ω3-fatty acids eicos-
apentaenoic acid (= EPA, 20:5Δ5,8,11,14,17) and docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,17,19) are synthesized via the
sequence of desaturase and elongase reactions. The application of ω3-fatty acids shows the therapeutic activity described
above in the treatment of cardiovascular diseases (Shimikawa 2001, World Rev. Nutr. Diet. 88, 100-108), inflammations
(Calder 2002, Proc. Nutr. Soc. 61, 345-358) and arthritis (Cleland and James 2000, J. Rheumatol. 27, 2305-2307).
[0015] Higher plants comprise polyunsaturated fatty acids such as linoleic acid (C18:2) and linolenic acid (C18:3).
ARA, EPA and DHA are not found at all in the seed oil of higher plants, or only in miniscule amounts (E. Ucciani: Nouveau
Dictionnaire des Huiles Végétales [New Dictionary of Vegetable Oils]. Technique & Documentation - Lavoisier, 1995.
ISBN: 2-7430-0009-0). However, the production of LCPUFAs in higher plants (preferably in oil crops such as oilseed
rape, linseed, sunflower and soybeans) would be advantageous since large amounts of high-quality LCPUFAs for the
food industry, animal nutrition and pharmaceutical purposes might be obtained economically. A potential route is via
recombinant methods, where genes which code for enzymes of the biosynthesis of LCPUFAs are introduced and ex-
pressed. These genes code for, for example, Δ6-desaturases, Δ6-elongases, Δ5-desaturases or Δ4-desaturases. These
genes can advantageously be isolated from microorganisms and lower plants which produce LCPUFAs and incorporate
them in the membranes or triacylglycerides. Thus, it has already been possible to isolate Δ6-desaturase genes from the
moss Physcomitrella patens and Δ6-elongase genes from P. patens and from the nematode C. elegans. (Zank, T.K. et
al. Plant Journal 31:255-268, 2002, Beaudoin et al. Biochem Soc Trans 28 :661-663, 2000).
[0016] The first transgenic plants which comprise and express genes coding for LCPUFA biosynthesis enzymes and
which produce LCPUFAs were described for the first time, for example, in DE-A-102 19 203 (method for the production
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of polyunsaturated fatty acids in plants). However, these plants produce LCPUFAs in amounts which require further
optimization for methoding the oils which are present in the plants.
[0017] To make possible the fortification of food and of feed with these polyunsaturated fatty acids, there is therefore
a great need for a simple, inexpensive method for the production of these polyunsaturated fatty acids, specifically in
eukaryotic systems.
[0018] The object on which the present invention is based is the provision of such means and measures. This object
is achieved by the embodiments which are described in the patent claims and hereinbelow.
[0019] The present invention thus relates to a polynucleotide comprising a nucleic acid sequence selected from the
group consisting of:
(a) nucleic acid sequence as shown in any of SEQ ID No. 1;
(b) nucleic acid sequence which codes for a polypeptide having an amino acid sequence as shown in any of SEQ
ID No. 2;
(c) nucleic acid sequence which hybridizes to a nucleic acid of (a) or (b) under stringent hybridization conditions,
wherein stringent hybridization conditions are hybridizations in 6 x sodium chloride/sodium citrate (SSC) at approx-
imately 45 °C, followed by one or more wash steps in 0.2 x SSC, 0.1 % SDS at 50 to 65 °C and wherein the nucleic
acid sequence codes for a polypeptide with Δ5 desaturase activity and acyl CoA specificity.
[0020] According to the invention, the term "polynucleotide" refers to polynucleotides which comprise nucleic acid
sequences which code for polypeptides with desaturase activity. The desaturase activities are preferably required for
the biosynthesis of lipids or fatty acids. Especially preferably, they take the form of the following desaturase activity: Δ5-
desaturase activity. The desaturase is preferably involved in the synthesis of polyunsaturated fatty acids (PUFAs) and
especially preferably in the synthesis of long-chain PUFAs (LCPUFAs). Suitable detection systems for this desaturase
activity are described in the examples or in WO 2005/083053. The specific polynucleotides according to the invention,
i.e. the polynucleotide with a nucleic acid sequence as shown in SEQ ID No. 1 or polynucleotides which code for a
polypeptide with an amino acid sequence as shown in SEQ ID No. 2 have been obtained from Emiliana huxleyi. The
term also comprises variants of the abovementioned specific polynucleotides. These may take the form of homologous,
orthologous or paralogous sequences. Such variants comprise nucleic acid sequences which feature at least one base
substitution, one base addition or one base deletion, it being intended that the variants still code for a polypeptide with
the abovementioned biological activity of the respective starting sequence. Variants comprise polynucleotides which
are capable of hybridization with the abovementioned polynucleotides, under stringent conditions. Especially preferred
stringent conditions are known to the skilled worker and can be found in Current Protocols in Molecular Biology, John
Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6. A preferred example of stringent hybridization conditions are hybridizations in
6 x sodium chloride/sodium citrate (= SSC) at approximately 45°C, followed by one or more wash steps in 0.2 x SSC,
0.1% SDS at 50 to 65°C. The skilled worker knows that these hybridization conditions differ as a function of the type of
nucleic acid and, for example when organic solvents are present, with regard to the temperature and the buffer concen-
tration. Under "standard hybridization conditions", the temperature differs as a function of the type of nucleic acid between
42°C and 58°C in aqueous buffer with a concentration of from 0.1 to 5 x SSC (pH 7.2). If organic solvent is present in
the abovementioned buffer, for example 50% formamide, the temperature under standard conditions is approximately
42°C. The hybridization conditions for DNA:DNA hybrids are preferably for example 0.1 x SSC and 20°C to 45°C,
preferably between 30°C and 45°C. The hybridization conditions for DNA:RNA hybrids are preferably for example 0.1
x SSC and 30°C to 55°C, preferably between 45°C and 55°C. The abovementioned hybridization temperatures are
determined for example for a nucleic acid of approximately 100 bp (= base pairs) in length and a G + C content of 50%
in the absence of formamide. The skilled worker knows how to determine the hybridization conditions required with the
aid of textbooks, such as the one mentioned hereinabove, or from the following textbooks: Sambrook et al., Molecular
Cloning, Cold Spring Harbor Laboratory, 1989; Hames and Higgins (eds.) 1985, Nucleic Acids Hybridization: A Practical
Approach, IRL Press at Oxford University Press, Oxford; Brown (ed.) 1991, Essential Molecular Biology: A Practical
Approach, IRL Press at Oxford University Press, Oxford. As an alternative, variants of the specific polynucleotides
according to the invention may also be provided by polymerase chain reaction (PCR)-based methods. To this end, it is
possible first to derive primers from conserved sequences (for example sequences which code for functional domains
in the polypeptide). Conserved sequences can be determined by sequence comparisons with polynucleotides which
code for polypeptides with a similar activity. The template used may be DNA or cDNA from bacteria, fungi, plants or
animals. DNA fragments obtained by PCR can be used for screening suitable genomic libraries or cDNA libraries in
order to - if required - isolate the complete open reading frame of the polynucleotide and to determine it by sequencing.
Described variants comprise polynucleotides which comprise a nucleic acid sequence with at least 70%, at least 75%,
at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least
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88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at
least 97%, at least 98% or at least 99% (or a different percentage than mentioned herein) identity with one of the
abovementioned specific nucleic acid sequences and codes for a polypeptide with the respective biological activity. Also
described are polynucleotides which comprise nucleic acid sequences which code for a polypeptide with an amino acid
sequence with at least 70%, at least 75%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least
85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at
least 94%, at least 95%, at least 96%, at least 97%, at least 98% or at least 99% (or a different percentage than mentioned
herein) identity with one of the above-mentioned specific amino acid sequences and where the polypeptide has the
respective biological activity of the starting sequence.
[0021] The percentage of identical nucleotides or amino acids preferably relates to a sequence segment of at least
50% of the sequences to be compared, and especially preferably over the entire length of the sequences to be compared.
A multiplicity of programs which implement algorithms for such comparisons are described in the prior art and commercially
available. In particular, reference may be made to the algorithms of Needleman and Wunsch or Smith and Waterman,
which give particularly reliable results. These algorithms can preferably be implemented by the following programs:
PileUp (J. Mol. Evolution., 25, 351-360, 1987, Higgins 1989, CABIOS, 5: 151-153), Gap and BestFit (Needleman 1970,
J. Mol. Biol. 48; 443-453 and Smith 1981, Adv. Appl. Math. 2; 482-489), as part of the GCG software (Genetics Computer
Group, 575 Science Drive, Madison, Wisconsin, USA 53711, 1991). For the purposes of the present invention, it is
especially preferred to determine the percentage (%) of the sequence identity with the GAP program over the entire
sequence, with the following set parameters: Gap Weight: 50, Length Weight: 3, Average Match: 10.000 and Average
Mismatch: 0.000.
[0022] A polynucleotide which only comprises a fragment of the abovementioned nucleic acid sequences is also a
polynucleotide according to the invention. Here, it is intended that the fragment codes for a polypeptide which features
the biological activity of the starting sequence, or of the polypeptide which the latter codes for. Polypeptides which are
encoded by such polynucleotides therefore comprise, or consist of, domains of the abovementioned specific polypeptides
(starting polypeptides) which confer the biological activity. A fragment for the purposes of the invention preferably com-
prises at least 50, at least 100, at least 250 or at least 500 consecutive nucleotides of the abovementioned specific
sequences or codes for an amino acid sequence comprising at least 20, at least 30, at least 50, at least 80, at least 100
or at least 150 consecutive amino acids of one of the abovementioned specific amino acid sequences, and confers
biological activity, preferably desaturase activity, as described above.
[0023] The term "desaturase activity" as used in the present context refers to an enzymatic activity by which a dehy-
drogenation of fatty acids or fatty acid derivatives as substrates catalyzes. The desaturase activity according to the
invention preferably takes the form of deta-5 desaturase (also referred to as Δ5-desaturase activity). Δ5-Desaturases
are enzymes with the enzymatic function for the dehydrogenation of C20 fatty acids which are dehydrogenated at the
C atom 8-9. Here, the C atoms C5 and C6 are dehydrogenated by in each case one hydrogen atom, giving rise to a
double bond between the two C atoms. It is especially preferred that enzymes with desaturase activity - and in particular
Δ5-desaturase activity - within the meaning of the present invention convert acyl-coenzyme A as substrate.
[0024] The polynucleotide variants according to the invention preferably feature at least 10%, at least 20%, at least
30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80% or at least 90% of the respective biological
activity of the polypeptide which is encoded by the starting sequence. That is to say the polypeptides which are encoded
by the polynucleotides according to the invention can participate in the metabolism of compounds required for the
synthesis of fatty acids, fatty acid esters such as diacylglycerides and/or triacylglycerides in an organism, preferably in
a plant or plant cell, or can participate in the transport of molecules across membranes, which means C18-, C20- or
C22-carbon chains in the fatty acid molecule with double bonds at at least two, advantageously three, four, five or six
positions.
[0025] The polynucleotides according to the invention either comprise the abovementioned specific nucleic acid se-
quences or consist of them. That is to say, that the polynucleotides according to the invention may, in principle, also
comprise further nucleotides. These may preferably be 3’- or 5’-untranslated regions of the genomic nucleic acid se-
quence. They preferably consist of at least 100, 200 or 500 nucleotides at the 5’ terminus and of at least 20, 50 or 100
nucleotides at the 3’ terminus of the coding region. Further polynucleotides which comprise additional nucleic acid
sequences are those which code for fusion proteins. Such fusion proteins can code for further polypeptide or polypeptide
portions, in addition to the abovementioned polypeptides. The additional polypeptide or polypeptide portion may take
the form of further enzymes of lipid or fatty acid biosynthesis. Others which are feasible are polypeptides which may act
as expression markers (green, yellow, red, blue fluorescent proteins, alkaline phosphatase and others) or so-called
"tags" as labels or as an aid for purification (for example FLAG tags, 6-histidine tags, MYC tags and others).
[0026] Polynucleotide variants can be isolated from different natural or artificial sources. For example, they can be
generated artificially by in-vitro or in-vivo mutagenesis. Homologs or orthologs of the specific sequences can be obtained
from a wide range of animals, plants and microorganisms. They are preferably obtained from algae. Algae such as
Isochrysis, Euglena or Crypthecodinium, algae/diatoms such as Thalassiosira, Phaeodactylum or Thraustochytrium,
EP 2 281 051 B1
7
5
10
15
20
25
30
35
40
45
50
55
Pythium, mosses such as Physcomitrella or Ceratodon are preferred, very especially preferred are the algae of the
genus Euglena or the diatoms of the class Oomycota such as the genera Pythium or Phytophtora or fungi from the
division Zygomywta from the genera Rhizopus. The polynucleotides can also be preferably be obtained from higher
plants such as Primulaceae such as Aleuritia, Calendula stellata, Osteospermum spinescens or Osteospermum hyose-
roides, microorganisms such as fungi, such as Aspergillus, Thraustochytrium, Phytophthora, Entomophthora, Mucor or
Mortierella, bacteria such as Shewanella, yeasts or animals such as nematodes, for example Caenorhabditis, insects
or fish. The polynucleotide variants are also preferably derived from an animal from the order vertebrates. Especially
preferably, the polynucleotides are derived from the class Vertebrata; Euteleostomi, Actinopterygii; Neopterygii; Teleostei;
Euteleostei, Protacanthopterygii, Salmoniformes; Salmonidae or Oncorhynchus and, very especially preferably, from
the order Salmoniformes such as the family Salmonidae, such as the genus Salmo, for example from the genera and
species Oncorhynchus mykiss, Trutta trutta or Salmo trutta fario. Here, the polynucleotides according to the invention
can be isolated by means of standard techniques of molecular biology and of the sequence information provided herein.
Also, it is possible, with the aid of comparative algorithms, to identify for example a homologous sequence or homologous,
conserved sequence regions at the DNA or amino acid level. These can be employed as hybridization probe and standard
hybridization techniques (such as, for example, those described in Sambrook et al., Molecular Cloning: A Laboratory
Manual. 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989)
for isolating further nucleic acid sequences which are useful in the method. Moreover, it is possible to isolate polynucle-
otides or fragments thereof by means of polymerase chain reaction (PCR), where oligonucleotide primers which are
based on this sequence or parts thereof are employed (for example, a nucleic acid molecule comprising the complete
sequence or part thereof can be isolated by polymerase chain reaction using oligonucleotide primers which have been
generated on the basis of this same sequence). For example, it is possible to isolate mRNA from cells (for example by
the guanidinium thiocyanate extractive method by Chirgwin et al. (1979) Biochemistry 18:5294-5299, and cDNA can be
generated by means of reverse transcriptase (for example Moloney MLV reverse transcriptase, obtainable from Gib-
co/BRL, Bethesda, MD, or AMV reverse transcriptase, obtainable from Seikagaku America, Inc., St.Petersburg, FL).
Synthetic oligonucleotide primers for the amplification by means of polymerase chain reaction can be generated on the
basis of the polynucleotide and amino acid sequences shown in the SEQ ID numbers. A nucleic acid according to the
invention can be amplified using cDNA or, alternatively, genomic DNA as the template and suitable oligonucleotide
primers, following standard PCR amplification techniques. The nucleic acid amplified thus can be cloned into a suitable
vector and characterized by means of DNA sequence analysis. Oligonucleotides which correspond to a desaturase
nucleotide sequence can be generated by standard synthetic methods, for example using an automatic DNA synthesizer.
[0027] The polynucleotides according to the invention can either be provided in the form of isolated polynucleotides
(i.e. isolated from their natural origin, for example the genomic locus) or else in genetically modified form (i.e. the
polynucleotides may also be present at their natural genetic locus, but, in such a case, must be genetically modified).
An isolated polynucleotide preferably comprises less than 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleic acid
sequence which occurs naturally in its environment. The polynucleotide according to the invention may be present as
a single-stranded or double-stranded nucleic acid molecule and may take the form of genomic DNA, cDNA or RNA.
Preferably, the polynucleotide according to the invention consists of RNA or DNA. The polynucleotides according to the
invention comprise all orientations of the sequences shown in the SEQ ID numbers, i.e. also complementary strands
and reverse, or reverse-complementary, orientations. The term furthermore also comprises chemically modified nucleic
acids, such as the naturally occurring methylated DNA molecules, or artificial nucleic acids, for example biotinylated
nucleic acids.
[0028] Owing to the polynucleotides according to the invention, the substrates 20:4Δ5,8,11,14 and 20:5Δ5,8,11,14,17 can
be increased in the recombinant production of long-chain PUFAs. The Δ5-desaturase which is encoded by the polynu-
cleotide according to the invention preferentially catalyzes the final synthesis step of 20:3Δ8,11,14 and 20:4Δ8,11,14,17
to give the commercially valuable long-chain polyunsaturated fatty acids. A variety of approaches for isolating Δ5-
desaturases have been carried out in the past (for example Domergue et al. (2002), Eur J Biochem. 269(16):4105-13,
Kajikawa et al. (2004) Plant Mol. Biol. 54:335-52). It has also been possible to demonstrate that all of the previously
known Δ5-desaturases utilize the same acyl carrier phosphatidylcholin (Domergue et al. (2003) J Biol Chem.
278(37):35115-26). For Δ6-desaturases, it has been possible to demonstrate that the conversion of acyl-coenzyme A
(acyl-carrier coenzyme A) is advantageous for the synthesis of long-chain polyunsaturated fatty acids (Domergue et al.
(2005) Biochem J. 389(Pt 2):483-90). However, it has not been possible to date to identify any enzyme for the class of
the Δ5-desaturases which is capable of converting acyl-coenzyme A as the substrate. Neither do sequence comparisons
make it possible to predict the substrate specificity with regard to the acyl carrier. Surprisingly, it was possible to isolate,
in the context of the present invention, a sequence from the alga Emiliana huxleyi (Eukaryota; Haptophyceae; Isochry-
sidales; Noelaerhabdaceae), which codes for an enzyme with Δ5-desaturase activity and which converts acyl-coenzyme
A substrates. In particular, it has emerged, advantageously, that the polynucleotides according to the invention can be
employed particularly efficiently for the recombinant production of polyunsaturated fatty acids in host cells and transgenic
organisms. In particular, the polypeptides with Δ5-desaturase activity which are encoded by the polynucleotide according
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to the invention are capable of C18-, C20- and C22-fatty acids with two, three, four or five double bonds and preferably
polyunsaturated C20-fatty acids with three or four double bonds such as C20:3Δ8,11,14 or C20:4Δ8,11,14,17. The polynu-
cleotide and amino acid sequences according to the invention especially preferably lead to an increase in the fatty acids
20:4Δ5,8,11,14 (arachidonic acid) and 20:5Δ5,8,11,14,17 (eicosapentaenoic acid).
[0029] Described are also oligonucleotides of at least 15 bp, preferably at least 20 bp, at least 25 bp, at least 30 bp,
at least 35 bp or at least 50 bp, which are capable of specifically hybridizing under stringent conditions with one of the
abovementioned polynucleotides. The oligonucleotides may consist of DNA or RNA or both. Such oligonucleotides can
be employed as primers for the PCR, as expression-inhibitory antisense oligonucleotides, for RNA interference (RNAi)
approaches or for chimeroplastic or genoplastic approaches. RNAi methods are described for example in Fire et al.,
Nature (1998) 391:806-811; Fire, Trends Genet. 15, 358-363 (1999); Sharp, RNA interference 2001. Genes Dev.
15,485-490 (2001); Hammond et al. Nature Rev. Genet. 2, 1110-1119 (2001); Tuschl, Chem. Biochem. 2, 239-245
(2001); Hamilton et al., Science 286, 950-952 (1999); Hammond et al., Nature 404, 293-296 (2000); Zamore et al., Cell
101, 25-33 (2000); Bernstein et al., Nature 409, 363-366 (2001); Elbashir et al., Genes Dev. 15, 188-200 (2001); WO
01/29058; WO 99/32619; or Elbashir et al., 2001 Nature 411: 494-498 and serve for inhibiting gene expression by
degrading the mRNA. Chimeroplastic or genoplastic approaches serve the in-vivo modification (for example the intro-
duction of point mutations) into genes at their endogenous loci. Corresponding methods are disclosed in US5,565,350,
US5,756,325, US5,871,984, US5,731,181, US5,795,972, US6,573,046, US6,211,351, US6,586,184, US6,271,360 and
US6,479,292.
[0030] In this context, it is especially preferred to employ the Δ6-desaturase encoded by the polynucleotide sequence
with SEQ ID No. 5 (d6Des(Pir)), the Δ6-elongase encoded by the polynucleotide sequence with SEQ ID No. 7 (d6Elo(Pp)),
the Δ5-desaturase encoded by the polynucleotide sequence with SEQ ID No. 1 (dSDes(Eh)), the Δ12-desaturase encoded
by the polynucleotide sequence with SEQ ID No. 9 (d12Des(Ps)), the Δ15-desaturase encoded by the polynucleotide
sequence with SEQ ID No. 13 (d15Des(Perf)), the ω3-desaturase encoded by the polynucleotide sequence with SEQ
ID No. 11 (o3Des(Pi)), the Δ5-elongase encoded by the polynucleotide sequence with SEQ ID No. 15 (d5Elo(Ot)), and
the Δ4-desaturase encoded by the polynucleotide sequence with SEQ ID No. 17 (d4Des(Tc)) with the desaturase
according to the invention in order to synthesize long-chain polyunsaturated fatty acids. The abovementioned polynu-
cleotides are described in WO2006/100241. Alternatively, it was also possible to employ a Δ9-elongase and a Δ8-
desaturase instead of the abovementioned Δ6-desaturase and the Δ6-elongase as described in WO2004/057001. De-
pending on the fatty acid which is to be prepared, it is possible to coexpress, in the host cells or transgenic organisms
described hereinbelow, or to use in the methods according to the invention, a variety of combinations of the polynucleotides
according to the invention with the abovementioned desaturases or elongases. Especially preferred combinations for
the production of arachidonic acid in table 1, for eicosapentaenoic acid in table 2 and for docosahexaenoic acid in table
3 are detailed hereinbelow. For example, it is possible to use the Δ5-desaturase according to the invention, alone or in
a suitable combination (for example a Δ12-desaturase and a Δ15-desaturase), together with d6Des(Pir), d6Elo(Pp),
d5Des(Tc), Δ3Des(Pi) for the production of EPA. Equally, the Δ5-desaturase according to the invention, alone or in a
suitable combination, can be used together with d6Des(Pir), d6Elo(Pp), d5Des(Tc), ω3Des(Pi), d5Elo(Ot), d4Des(Tc)
for the production of docosahexaenoic acid.
[0031] Preferably, it is the fatty acids in phospholipids or CoA fatty acid esters which are desaturated, advantageously
in the CoA fatty acid esters. Thus, a simple, inexpensive production of these polyunsaturated fatty acids is possible,
specifically in eukaryotic systems. The unsaturated fatty acids produced by means of the polynucleotides according to
the invention can then be formulated as oil, lipid and fatty acid compositions and can be employed in a suitable manner.
[0032] The present invention furthermore relates to a vector which comprises the polynucleotide according to the
invention.
[0033] The term "vector" refers to a nucleic acid molecule which is capable of transporting another nucleic acid molecule,
such as the polynucleotides according to the invention, to which it is bound. One type of vector is a "plasmid", a circular
double-stranded DNA loop into which additional DNA segments can be ligated. A further type of vector is a viral vector,
it being possible for additional DNA segments to be ligated into the viral genome. Certain vectors are capable of auton-
omous replication in a host cell into which they have been introduced (for example bacterial vectors with bacterial
replication origin). Other vectors are advantageously integrated into the genome of a host cell when they are introduced
into the host cell, and thus replicate together with the host genome. Moreover, certain vectors can govern the expression
of genes with which they are in operable linkage. These vectors are referred to in the present context as "expression
vectors". Usually, expression vectors which are suitable for DNA recombination techniques take the form of plasmids.
In the present description, "plasmid" and "vector" can be used exchangeably since the plasmid is the form of vector
which is most frequently used. However, the invention is also intended to comprise other forms of expression vectors,
such as viral vectors, which exert similar functions. Furthermore, the term "vector" is also intended to comprise other
vectors with which the skilled worker is familiar, such as phages, viruses such as SV40, CMV, TMV, transposons, IS
elements, phasmids, phagemids, cosmids, linear or circular DNA, artificial chromosomes. Finally, the term also comprises
constructs for the targeted, i.e. homologous, recombination, or the heterologous insertion of polynucleotides.
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[0034] Vectors can be introduced into prokaryotic and eukaryotic cells via conventional transformation or transfection
techniques. The terms "transformation" and "transfection", conjugation and transduction, as used in the present context,
are intended to comprise a multiplicity of methods known in the prior art for the introduction of foreign nucleic acid (for
example DNA) into a host cell, including calcium phosphate or calcium chloride coprecipitation, DEAE-dextran-mediated
transfection, lipofection, natural competence, chemically mediated transfer, electroporation or particle bombardment.
Suitable methods for the transformation or transfection of host cells, including plant cells, can be found in Sambrook et
al. (Molecular Cloning: A Laboratory Manual., 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY, 1989) and other laboratory textbooks such as Methods in Molecular Biology, 1995, Vol.
44, Agrobacterium protocols, Ed.: Gartland and Davey, Humana Press, Totowa, New Jersey.
[0035] Suitable cloning vectors are generally known to the skilled worker. In particular, they include vectors which can
replicate in microbial systems, that is mainly vectors which ensure efficient cloning in yeasts or fungi and which make
possible the stable transformation of plants. Those which must be mentioned are in particular various binary and cointe-
grated vector systems which are suitable for the T-DNA-mediated transformation. Such vector systems are, as a rule,
characterized in that they comprise at least the vir genes, which are required for the agrobacterium-mediated transfor-
mation, and the T-DNA-bordering sequences (T-DNA border). Preferably, these vector systems also comprise further
cis-regulatory regions such as promoters and terminators and/or selection markers, by means of which suitably trans-
formed organisms can be identified. While in the case of cointegrated vector systems vir genes and T-DNA sequences
are arranged on the same vector, binary systems are based on at least two vectors, one of which bears vir genes, but
no T-DNA, and the other bears T-DNA, but no vir gene. As a result, the last-mentioned vectors are relatively small, easy
to manipulate and to replicate both in E. coli and in Agrobacterium. These binary vectors include vectors from the pBIB-
HYG series, the pPZP series, the pBecks series and the pGreen series. Preferably used according to the invention are
Bin19, pBI101, pBinAR, pGPTV and pCAMBIA. An overview of binary vectors and their use is found in Hellens et al,
Trends in Plant Science (2000) 5, 446-451. The vectors with the inserted polynucleotides according to the invention can
be propagated stably under selective conditions in microorganisms, in particular Escherichia coli and Agrobacterium
tumefaciens, and make possible a transfer of heterologous DNA into plants or microorganisms. The polynucleotides
according to the invention can be introduced into organisms such as microorganisms or plants by means of the cloning
vectors and thus used for transforming plants. Vectors which are suitable for this purpose are published in: Plant Molecular
Biology and Biotechnology (CRC Press, Boca Raton, Florida), chapter 6/7, p. 71-119 (1993); F.F. White, Vectors for
Gene Transfer in Higher Plants; in: Transgenic Plants, vol. 1, Engineering and Utilization, eds.: Kung and R. Wu, Academic
Press, 1993, 15-38; B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, vol. 1, Engineering and
Utilization, eds.: Kung and R. Wu, Academic Press (1993), 128-143; Potrykus, Annu. Rev. Plant Physiol. Plant Molec.
Biol. 42 (1991), 205-225.
[0036] The vector is preferably an expression vector. The polynucleotide is present in the expression vector according
to the invention in operative (i.e. functional) linkage with an expression control sequence. The expression control sequence
together with the polynucleotide and optionally further sequence elements of the vector is also referred to as the expression
cassette. The expression control sequence ensures that, after transformation or transfection into a host cell, the poly-
nucleotide can be expressed. The expression control sequence to be used preferably comprises cis-regulatory elements
such as promoter and/or enhancer nucleic acid sequences, which are recognized by the transcription machinery of the
host cells. The term furthermore comprises other expression control elements, for example polyadenylation signals and
RNA-stabilizing sequences. These regulatory sequences are described for example in Goeddel: Gene Expression Tech-
nology: Methods in Enzymology 185, Academic Press, San Diego, CA (1990) or see: Gruber and Crosby, in: Methods
in Plant Molecular Biology and Biotechnology, CRC Press, Boca Raton, Florida, eds.: Glick and Thompson, chapter 7,
89-108, including the literature cited therein. Expression control sequences comprise those which govern the constitutive
expression of a nucleotide sequence in many types of host cells, and those which govern the direct expression of the
nucleotide sequence only in certain host cells under certain conditions. The skilled worker knows that the design of the
expression vector may depend on factors such as the choice of the host cell to be transformed, the extent of the expression
of the desired protein and the like. The polynucleotides according to the invention may be present in one or more copies
in the expression cassette or in the expression vector according to the invention (for example in the form of several
expression cassettes). Here, the regulatory sequences or factors can preferably have a positive effect on the gene
expression of the introduced genes, as described above, and thereby increase it. Thus, it is possible to enhance the
regulatory elements advantageously at the transcription level by using strong transcription signals such as promoters
and/or "enhancers". Besides, it is also possible to enhance the translation, for example by improving the mRNA stability.
Further expression control sequences within the meaning of the present invention are translation terminators at the 3’
end of the polynucleotides to be translated. An example which can be used here is the OCS1 terminator. As in the case
of the promoters, a different terminator sequence should be used for each polynucleotide to be expressed.
[0037] Preferred expression control sequences or regulatory sequences are present in promoters such as the cos,
tac, trp, tet, trp-tet, Ipp, lac, Ipp-lac, laclq, T7, T5, T3, gal, trc, ara, SP6, λ-PR or λ-PL promoters and are advantageously
employed in Gramnegative bacteria. Further advantageous regulatory sequences are, for example, present in the Gram-
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positive promoters amy and SPO2, in the yeast or fungal promoters ADC1, MFα, AC, P-60, CYC1, GAPDH, TEF, rp28,
ADH or in the plant promoters CaMV/35S [Franck et al., Cell 21 (1980) 285-294], PRP1 [Ward et al., Plant. Mol. Biol.
22 (1993)], SSU, OCS, lib4, usp, STLS1, B33, nos or in the ubiquitin or phaseolin promoter. Advantageous in this context
are also inducible promoters, such as the promoters described in EP-A-0 388 186 (benzenesulfonamide-inducible),
Plant J. 2, 1992:397-404 (Gatz et al., tetracycline-inducible), EP-A-0 335 528 (abscisic acid-inducible) or WO 93/21334
(ethanol- or cyclohexenol-inducible). Further suitable plant promoters are the cytosolic FBPase promoter or the ST-LSI
promoter of potato (Stockhaus et al., EMBO J. 8, 1989, 2445), the glycine max phosphoribosylpyrophosphate ami-
dotransferase promoter (Genbank Accession No. U87999) or the node-specific promoter described in EP-A-0 249 676.
Especially advantageous promoters are promoters which make possible the expression in tissues which are involved
in the biosynthesis of fatty acids. Very especially advantageous are seed-specific promoters, such as the USP promoter,
but also other promoters such as the LeB4, DC3, phaseolin or napin promoter. Further especially advantageous promoters
are seed-specific promoters which can be used for monocotyledonous or dicotyledonous plants and which are described
in US 5,608,152 (oilseed rape napin promoter), WO 98/45461 (Arobidopsis oleosin promoter), US 5,504,200 (Phaseolus
vulgaris phaseolin promoter), WO 91/13980 (Brassica Bce4 promoter), by Baeumlein et al., Plant J., 2, 2, 1992:233-239
(LeB4 promoter from a legume), these promoters being suitable for dicots. Examples of promoters which are suitable
for monocots are the barley Ipt-2 or Ipt-1 promoter (WO 95/15389 and WO 95/23230), the barley hordein promoter and
other suitable promoters described in WO 99/16890. In principle, it is possible to use all natural promoters together with
their regulatory sequences, such as those mentioned above, as expression control sequences. It is also possible to use
synthetic promoters, either in addition or alone, in particular when they mediate seed-specific expression, as described,
for example, in WO 99/16890.
[0038] In order to achieve a particularly high PUFA content, especially in transgenic plants, the polynucleotides of the
present invention should preferably be expressed in oil crops in a seed-specific manner. To this end, seed-specific
promoters can be used, or those promoters which are active in the embryo and/or in the endosperm. In principle, seed-
specific promoters can be isolated both from dicotyledonous and from monocotyledonous plants. Advantageous preferred
promoters are listed hereinbelow: USP (= unknown seed protein) and vicilin (Vicia faba) [Bäumlein et al., Mol. Gen
Genet., 1991, 225(3)], napin (oilseed rape) [US 5,608,152], acyl carrier protein (oilseed rape) [US 5,315,001 and WO
92/18634], oleosin (Arabidopsis thaliana) [WO 98/45461 and WO 93/20216], phaseolin (Phaseolus vulgaris) [US
5,504,200], Bce4 [WO 91/13980], legumines B4 (LegB4 promoter) [Bäumlein et al., Plant J., 2,2, 1992], Lpt2 and Ipt1
(barley) [WO 95/15389 and WO 95/23230], seed-specific promoters from rice, maize and wheat [WO 99/16890], Amy32b,
Amy 6-6 and aleurain [US 5,677,474], Bce4 (oilseed rape) [US 5,530,149], glycinin (soybean) [EP 571 741], phosphoenol
pyruvate carboxylase (soybean) [JP 06/62870], ADR12-2 (soybean) [WO 98/08962], isocitrate lyase (oilseed rape) [US
5,689,040] or α-amylase (barley) [EP 781 849].
[0039] Plant gene expression can also be facilitated via a chemically inducible promoter (see a review in Gatz 1997,
Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are particularly suitable when it
is desired that gene expression should take place in a time-specific manner. Examples of such promoters are a salicylic
acid-inducible promoter (WO 95/19443), a tetracycline-inducible promoter (Gatz et al. (1992) Plant J. 2, 397-404) and
an ethanol-inducible promoter.
[0040] To ensure stable integration of the various biosynthesis genes into the transgenic plant over a plurality of
generations, each of the polynucleotides according to the invention should be expressed under the control of a separate
promoter, preferably a promoter which differs from the other promoters, since repeating sequence motifs can lead to
instability of the T-DNA, or to recombination events. In this context, the expression cassette is advantageously constructed
in such a way that a promoter is followed by a suitable cleavage site (advantageously in a polylinker) for insertion of the
nucleic acid to be expressed and, if appropriate, a terminator is then positioned behind the polylinker. This sequence is
repeated several times, preferably three, four or five times, so that up to five genes can be combined in one construct
and introduced into the transgenic plant in order to be expressed. Advantageously, the sequence is repeated up to three
times. To express the nucleic acid sequences, the latter are inserted behind the promoter via a suitable cleavage site,
for example in the polylinker. Advantageously, each nucleic acid sequence has its own promoter and, if appropriate, its
own terminator. Such advantageous constructs are disclosed, for example, in DE 101 02 337 or DE 101 02 338. However,
it is also possible to insert a plurality of nucleic acid sequences behind a promoter and, if appropriate, in front of a
terminator. Here, the insertion site, or the sequence, of the inserted nucleic acids in the expression cassette is not of
critical importance, that is to say a nucleic acid sequence can be inserted at the first or last position in the cassette
without its expression being substantially influenced thereby. Advantageously, different promoters such as, for example,
the USP, LegB4 or DC3 promoters, and different terminators can be used in the expression cassette. However, it is also
possible to use only one type of promoter in the cassette. This, however, may lead to undesired recombination events.
[0041] The recombinant expression vectors used can be designed for the expression in prokaryotic or eukaryotic cells.
This is advantageous since intermediate steps of the vector construction are frequently carried out in microorganisms
for the sake of simplicity. For example, the Δ12-desaturase, Δ15-desaturase, Δ12- and Δ15-desaturases, ω3-desaturase,
Δ6-desaturase, ω6-elongase, ω9-elongase, Δ8-desaturase, Δ5-desaturase, ω5-elongase and/or Δ4-desaturase genes
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can be expressed in bacterial cells, insect cells (using Baculovirus expression vectors), yeast and other fungal cells (see
Romanos, M.A., et al. (1992) "Foreign gene expression in yeast: a review", Yeast 8:423-488; van den Hondel, C.A.M.J.J.,
et al. (1991) "Heterologous gene expression in filamentous fungi", in: More Gene Manipulations in Fungi, J.W. Bennet
& L.L. Lasure, Eds., pp. 396-428: Academic Press: San Diego; and van den Hondel, C.A.M.J.J., & Punt, P.J. (1991)
"Gene transfer systems and vector development for filamentous fungi, in: Applied Molecular Genetics of Fungi, Peberdy,
J.F., et al., Eds., pp. 1-28, Cambridge University Press: Cambridge), algae (Falciatore et al., 1999, Marine Biotechnol-
ogy.1, 3:239-251), ciliates of the types: Holotrichia, Peritrichia, Spirotrichia, Suctoria, Tetrahymena, Paramecium, Col-
pidium, Glaucoma, Platyophrya, Potomacus, Desaturaseudocohnilembus, Euplotes, Engelmaniella and Stylonychia, in
particular of the genus Stylonychia lemnae, using vectors in a transformation method as described in WO 98/01572 and,
preferably, in cells of multi-celled plants (see Schmidt, R. and Willmitzer, L. (1988) "High efficiency Agrobacterium
tumefaciens-mediated transformation of Arabidopsis thaliana leaf and cotyledon explants" Plant Cell Rep.:583-586;
Plant Molecular Biology and Biotechnology, C Press, Boca Raton, Florida, Chapter 6/7, pp. 71-119 (1993); F.F. White,
B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, Eds.: Kung
and R. Wu, Academic Press (1993), 128-43; Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225
(and references cited therein)). Suitable host cells are furthermore discussed in Goeddel, Gene Expression Technology:
Methods in Enzymology 185, Academic Press, San Diego, CA (1990). As an alternative, the recombinant expression
vector can be transcribed and translated in vitro, for example using T7-promoter regulatory sequences and T7-polymer-
ase.
[0042] In most cases, the expression of proteins in prokaryotes involves the use of vectors comprising constitutive or
inducible promoters which govern the expression of fusion or nonfusion proteins. Typical fusion expression vectors are,
inter alia, pGEX (Pharmacia Biotech Inc; Smith, D.B., and Johnson, K.S. (1988) Gene 67:31-40), pMAL (New England
Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ), where glutathione S-transferase (GST), maltose-E-
binding protein and protein A, respectively, are fused with the recombinant target protein. Examples of suitable inducible
nonfusion E. coli expression vectors are, inter alia, pTrc (Amann et al. (1988) Gene 69:301-315) and pET 11 d (Studier
et al., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California (1990) 60-89).
The target gene expression from the vector pTrc is based on the transcription from a hybrid trp-lac fusion promoter by
the host RNA polymerase. The target gene expression from the vector pET 11 d is based on the transcription of a T7-
gn10-lac fusion promoter, which is mediated by a viral RNA polymerase (T7 gn1), which is coexpressed. This viral
polymerase is provided by the host strains BL21 (DE3) or HMS174 (DE3) from a resident λ-prophagene which harbors
a T7 gn1 gene under the transcriptional control of the lacUV 5 promoter. Other vectors which are suitable for prokaryotic
organisms are known to the skilled worker, these vectors are, for example in E. coli pLG338, pACYC184, the pBR series
such as pBR322, the pUC series such as pUC18 or pUC19, the M113mp series, pKC30, pRep4, pHS1, pHS2, pPLc236,
pMBL24, pLG200, pUR290, pIN-III113-B1, λgt11 or pBdCl, in Streptomyces pIJ101, pIJ364, pIJ702 or pIJ361, in Bacillus
pUB110, pC194 or pBD214, in Corynebacterium pSA77 or pAJ667.
[0043] In a further embodiment, the expression vector is a yeast expression vector. Examples of vectors for expression
in the yeast S. cerevisiae comprise pYeDesaturasec1 (Baldari et al. (1987) Embo J. 6:229-234), pMFa (Kurjan and
Herskowitz (1982) Cell 30:933-943), pJRY88 (Schultz et al. (1987) Gene 54:113-123) and pYES2 (Invitrogen Corporation,
San Diego, CA). Vectors and methods for the construction of vectors which are suitable for use in other fungi, such as
the filamentous fungi, comprise those which are described in detail in: van den Hondel, C.A.M.J.J., & Punt, P.J. (1991)
"Gene transfer systems and vector development for filamentous fungi, in: Applied Molecular Genetics of fungi, J.F.
Peberdy et al., Ed., pp. 1-28, Cambridge University Press: Cambridge, or in: More Gene Manipulations in Fungi [J.W.
Bennet & L.L. Lasure, Eds., pp. 396-428: Academic Press: San Diego]. Further suitable yeast vectors are, for example,
pAG-1, YEp6, YEp13 or pEMBLYe23.
[0044] As an alternative, the polynucleotides of the present invention can also be expressed in insect cells using
Baculovirus expression vectors. Baculovirus vectors which are available for the expression of proteins in cultured insect
cells (for example Sf9 cells) comprise the pAc series (Smith et al. (1983) Mol. Cell Biol.. 3:2156-2165) and the pVL series
(Lucklow and Summers (1989) Virology 170:31-39).
[0045] Preferred plant expression vectors comprise those which are described in detail in: Becker, D., Kemper, E.,
Schell, J., and Masterson, R. (1992) "New plant binary vectors with selectable markers located proximal to the left
border", Plant Mol. Biol. 20:1195-1197; and Bevan, M.W. (1984) "Binary Agrobacterium vectors for plant transformation",
Nucl. Acids Res. 12:8711-8721; Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, Vol. 1, Engineering
and Utilization, Eds.: Kung and R. Wu, Academic Press, 1993, p. 15-38. A plant expression cassette preferably comprises
expression control sequences which are capable of governing the expression of genes in plant cells and which are linked
operably so that each sequence can fulfill its function, such as transcriptional termination, for example polyadenylation
signals. Preferred polyadenylation signals are those which are derived from Agrobacterium tumefaciens T-DNA, such
as gene 3 of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984) 835 et seq.), which is known as octopine synthase,
or functional equivalents thereof, but all other terminators which are functionally active in plants are also suitable. Since
plant gene expression is very often not limited to transcriptional levels, a plant expression cassette preferably comprises
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other sequences which are linked operably, such as translation enhancers, for example the overdrive sequence, which
comprises the tobacco mosaic virus 5’-untranslated leader sequence, which increases the protein/RNA ratio (Gallie et
al., 1987, Nucl. Acids Research 15:8693-8711). As described above, plant gene expression must be linked operably
with a suitable promoter which triggers gene expression with the correct timing or in a cell- or tissue-specific manner.
Utilizable promoters are constitutive promoters (Benfey et al., EMBO J. 8 (1989) 2195-2202), such as those which are
derived from plant viruses, such as 35S CAMV (Franck et al., Cell 21 (1980) 285-294), 19S CaMV (see also US 5352605
and WO 84/02913), or plant promoters, such as the promoter of the small Rubisco subunit, which is described in US
4,962,028. Other preferred sequences for use in operable linkage in plant gene expression cassettes are targeting
sequences, which are required for steering the gene product into its corresponding cell compartment (see a review in
Kermode, Crit. Rev. Plant Sci. 15, 4 (1996) 285-423 and references cited therein), for example into the vacuole, into the
nucleus, all types of plastids, such as amyloplasts, chloroplasts, chromoplasts, the extracellular space, the mitochondria,
the endoplasmic reticulum, oil bodies, peroxisomes and other compartments of plant cells.
[0046] As described above, plant gene expression can also be facilitated via a chemically inducible promoter (see
review in Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are partic-
ularly suitable when it is desired that the gene expression takes place in a time-specific manner. Examples of such
promoters are a salicylic-acid-inducible promoter (WO 95/19443), a tetracyclininducible promoter (Gatz et al. (1992)
Plant J. 2, 397-404) and an ethanol-inducible promoter. Promoters which respond to biotic or abiotic stress conditions
are also suitable, for example the pathogen-induced PRP1 gene promoter (Ward et al., Plant. Mol. Biol. 22 (1993)
361-366), the heat-inducible tomato hsp80 promoter (US 5,187,267), the chill-inducible potato alpha-amylase promoter
(WO 96/12814) or the wound-inducible pinll promoter (EP-A-0 375 091).
[0047] Especially preferred are those promoters which bring about the gene expression in tissues and organs in which
the biosynthesis of fatty acids, lipids and oils takes place, in seed cells, such as the cells of the endosperm and of the
developing embryo. Suitable promoters are the oilseed rape napin gene promoter (US 5,608,152), the Vicia faba USP
promoter (Baeumlein et al., Mol Gen Genet, 1991, 225 (3):459-67), the Arabidopsis oleosin promoter (WO 98/45461),
the Phaseolus vulgaris phaseolin promoter (US 5,504,200), the Brassica Bce4 promoter (WO 91/13980) or the legumine
B4 promoter (LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):233-9), and promoters which bring about the seed-
specific expression in monocotyledonous plants such as maize, barley, wheat, rye, rice and the like. Suitable noteworthy
promoters are the barley Ipt2 or Ipt1 gene promoter (WO 95/15389 and WO 95/23230) or the promoters from the barley
hordein gene, the rice glutelin gene, the rice oryzin gene, the rice prolamine gene, the wheat gliadine gene, the wheat
glutelin gene, the maize zeine gene, the oat glutelin gene, the sorghum kasirin gene or the rye secalin gene, which are
described in WO 99/16890. Especially suitable promoters are likewise those which bring about the plastid-specific
expression, since plastids are the compartment in which the precursors and some of the end products of lipid biosynthesis
are synthesized. Suitable promoters, such as the viral RNA polymerase promoter, are described in WO 95/16783 and
WO 97/06250, and the clpP promoter from Arabidopsis, described in WO 99/46394.
[0048] The abovementioned vectors are only a small overview over possible vectors which are suitable. Further
plasmids are known to the skilled worker and are described for example in: Cloning Vectors (eds. Pouwels, P.H., et al.,
Elsevier, Amsterdam-New York-Oxford, 1985, ISBN 0 444 904018). Further suitable expression systems for prokaryotic
and eukaryotic cells, see chapters 16 and 17 of Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning: A
Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor,
NY, 1989.
[0049] As described above, the expression vector can, in addition to the polynucleotides according to the invention,
also comprise further genes which are to be introduced into the organisms. It is possible and preferred to introduce into
the host organisms, and express in them, regulatory genes, such as genes for inductors, repressors or enzymes which,
as a result of their enzymatic activity, engage in the regulation of one or more genes of a biosynthetic pathway. These
genes can be of heterologous or homologous origin. Heterologous genes or polynucleotides are derived from an organism
of origin which differs from the target organism into which the genes or polynucleotides are to be introduced. In the case
of homologous genes or polynucleotides, target organism and organism of origin are identical. The vector therefore
preferably comprises at least one further polynucleotide which codes for a further enzyme which is involved in the
biosynthesis of lipids or fatty acids. The enzyme is preferably selected from the group consisting of: acyl-CoA dehydro-
genase(s), acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty acid acyltransferase(s), acyl-
CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s), fatty acid hydroxylase(s), acetyl-coenzyme A carbox-
ylase(s), acyl-coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenase(s), lipoxygenase(s), triacylglycerol
lipase(s), allene oxide synthase(s), hydroperoxide lyase(s), fatty acid elongase(s), Δ4-desaturase(s), Δ5-desaturase(s),
Δ6-desaturase(s), Δ8-desaturase(s), Δ9-desaturase(s), Δ12-desaturase(s), Δ15-desaturase(s), Δ12- and Δ15-desatu-
rase(s), ω3-desaturase, Δ5-elongase(s), Δ6-elongase(s) and Δ9-elongase(s).
Especially preferred gene combinations are listed in tables 5 and 6 in the examples which follow.
[0050] The invention also relates to a host cell which comprises the polynucleotide according to the invention or the
vector according to the invention.
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[0051] In principle, host cells for the purposes of the present invention may be all eukaryotic or prokaryotic cells. They
may be primary cells from animals, plants or multi-celled microorganisms, for example from those which are mentioned
in another place in the description. The term furthermore also comprises cell lines which can be obtained from these
organisms.
[0052] However, host cells for the purposes of the invention may also be single-celled microorganisms, for example
bacteria or fungi. Especially preferred microorganisms are fungi selected from the group of the families Chaetomiaceae,
Choanephoraceae, Cryptococcaceae, Cunninghamellaceae, Demetiaceae, Moniliaceae, Mortierellaceae, Mucoraceae,
Pythiaceae, Sacharomycetaceae, Saprolegniaceae, Schizosacharomycetaceae, Sodariaceae or Tuberculariaceae. Fur-
ther preferred microorganisms are selected from the group: Choanephoraceae, such as the genera Blakeslea, Cho-
anephora, for example the genera and species Blakeslea trispora, Choanephora cucurbitarum, Choanephora infundibu-
lifera var. cucurbitarum, Mortierellaceae, such as the genus Mortierella, for example the genera and species Mortierella
isabellina, Mortierella polycephala, Mortierella ramanniana, Mortierella vinacea, Mortierella zonata, the family Mucorales,
such as the genera and species Rhizopus oryzae, Rhizopus stolonifer, Fusarium graminearium, Pythiaceae, such as
the genera Phytium, Phytophthora, for example the genera and species Pythium debaryanum, Pythium intermedium,
Pythium irregulare, Pythium megalacanthum, Pythium paroecandrum, Pythium sylvaticum, Pythium ultimum, Phytoph-
thora cactorum, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora, Phytophthora cryptogea,
Phytophthora drechsleri, Phytophthora erythroseptica, Phytophthora lateralis, Phytophthora megasperma, Phytophthora
nicotianae, Phytophthora nicotianae var. parasitica, Phytophthora palmivora, Phytophthora parasitica, Phytophthora
syringae, Saccharomycetaceae, such as the genera Hansenula, Pichia, Saccharomyces, Saccharomycodes, Yarrowia,
for example the genera and species Hansenula anomala, Hansenula californica, Hansenula canadensis, Hansenula
capsulata, Hansenula ciferrii, Hansenula glucozyma, Hansenula henricii, Hansenula holstii, Hansenula minuta, Hansenu-
la nonfermentans, Hansenula philodendri, Hansenula polymorpha, Hansenula saturnus, Hansenula subpelliculosa,
Hansenula wickerhamii, Hansenula wingei, Pichia alcoholophila, Pichia angusta, Pichia anomala, Pichia bispora, Pichia
burtonii, Pichia canadensis, Pichia capsulata, Pichia carsonii, Pichia cellobiosa, Pichia ciferrii, Pichia farinosa, Pichia
fermentans, Pichia finlandica, Pichia glucozyma, Pichia guilliermondii, Pichia haplophila, Pichia henricii, Pichia holstii,
Pichia jadinii, Pichia lindnerii, Pichia membranaefaciens, Pichia methanolica, Pichia minuta var. minuta, Pichia minuta
var. nonfermentans, Pichia norvegensis, Pichia ohmeri, Pichia pastoris, Pichia philodendri, Pichia pini, Pichia polymor-
pha, Pichia quercuum, Pichia rhodanensis, Pichia sargentensis, Pichia stipitis, Pichia strasburgensis, Pichia subpellic-
ulosa, Pichia toletana, Pichia trehalophila, Pichia vini, Pichia xylosa, Saccharomyces aceti, Saccharomyces bailii, Sac-
charomyces bayanus, Saccharomyces bisporus, Saccharomyces capensis, Saccharomyces carlsbergensis, Saccha-
romyces cerevisiae, Saccharomyces cerevisiae var. ellipsoideus, Saccharomyces chevalieri, Saccharomyces delbrueck-
ii, Saccharomyces diastaticus, Saccharomyces drosophilarum, Saccharomyces elegans, Saccharomyces ellipsoideus,
Saccharomyces fermentati, Saccharomyces florentinus, Saccharomyces fragilis, Saccharomyces heterogenicus, Sac-
charomyces hienipiensis, Saccharomyces inusitatus, Saccharomyces italicus, Saccharomyces kluyveri, Saccharomyces
krusei, Saccharomyces lactis, Saccharomyces marxianus, Saccharomyces microellipsoides, Saccharomyces montanus,
Saccharomyces norbensis, Saccharomyces oleaceus, Saccharomyces paradoxus, Saccharomyces pastorianus, Sac-
charomyces pretoriensis, Saccharomyces rosei, Saccharomyces rouxii, Saccharomyces uvarum, Saccharomycodes
ludwigii, Yarrowia lipolytica, Schizosaccharomycetaceae such as the genera Schizosaccharomyces e.g. the species
Schizosaccharomyces japonicus var. japonicus, Schizosaccharomyces japonicus var. versatilis, Schizosaccharomyces
malidevorans, Schizosaccharomyces octosporus, Schizosaccharomyces pombe var. malidevorans, Schizosaccharo-
myces pombe var. pombe, Thraustochytriaceae such as the genera Althornia, Aplanochytrium, Japonochytrium, Schizo-
chytrium, Thraustochytrium e.g. the species Schizochytrium aggregatum, Schizochytrium limacinum, Schizochytrium
mangrovei, Schizochytrium minutum, Schizochytrium octosporum, Thraustochytrium aggregatum, Thraustochytrium
amoeboideum, Thraustochytrium antacticum, Thraustochytrium arudimentale, Thraustochytrium aureum, Thrausto-
chytrium benthicola, Thraustochytrium globosum, Thraustochytrium indicum, Thraustochytrium kerguelense, Thrausto-
chytrium kinnei, Thraustochytrium motivum, Thraustochytrium multirudimentale, Thraustochytrium pachydermum,
Thraustochytrium proliferum, Thraustochytrium roseum, Thraustochytrium rossii, Thraustochytrium striatum or Thraus-
tochytrium visurgense.
[0053] Equally preferred as microorganisms are bacteria selected from the group of the families Bacillaceae, Entero-
bacteriacae or Rhizobiaceae. It is especially preferred to mention the following bacteria selected from the group: Bacil-
laceae, such as the genus Bacillus, for example the genera and species Bacillus acidocaldarius, Bacillus acidoterrestris,
Bacillus alcalophilus, Bacillus amyloliquefaciens, Bacillus amylolyticus, Bacillus brevis, Bacillus cereus, Bacillus circu-
lans, Bacillus coagulans, Bacillus sphaericus subsp. fusiformis, Bacillus galactophilus, Bacillus globisporus, Bacillus
globisporus subsp. marinus, Bacillus halophilus, Bacillus lentimorbus, Bacillus lentus, Bacillus licheniformis, Bacillus
megaterium, Bacillus polymyxa, Bacillus psychrosaccharolyticus, Bacillus pumilus, Bacillus sphaericus, Bacillus subtilis
subsp. spizizenii, Bacillus subtilis subsp. subtilis or Bacillus thuringiensis; Enterobacteriacae such as the genera Citro-
bacter, Edwardsiella, Enterobacter, Erwinia, Escherichia, Klebsiella, Salmonella or Serratia, for example the genera and
species Citrobacter amalonaticus, Citrobacter diversus, Citrobacter freundii, Citrobacter genomospecies, Citrobacter
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gillenii, Citrobacter intermedium, Citrobacter koseri, Citrobacter murliniae, Citrobacter sp., Edwardsiella hoshinae, Ed-
wardsiella ictaluri, Edwardsiella tarda, Erwinia alni, Erwinia amylovora, Erwinia ananatis, Erwinia aphidicola, Erwinia
billingiae, Erwinia cacticida, Erwinia cancerogena, Erwinia carnegieana, Erwinia carotovora subsp. atroseptica, Erwinia
carotovora subsp. betavasculorum, Erwinia carotovora subsp. odorifera, Erwinia carotovora subsp. wasabiae, Erwinia
chrysanthemi, Erwinia cypripedii, Erwinia dissolvens, Erwinia herbicola, Erwinia mallotivora, Erwinia milletiae, Erwinia
nigrifluens, Erwinia nimipressuralis, Erwinia persicina, Erwinia psidii, Erwinia pyrifoliae, Erwinia quercina, Erwinia rhapon-
tici, Erwinia rubrifaciens, Erwinia salicis, Erwinia stewartii, Erwinia tracheiphila, Erwinia uredovora, Escherichia adecar-
boxylata, Escherichia anindolica, Escherichia aurescens, Escherichia blattae, Escherichia coli, Escherichia coli var.
communior, Escherichia coli-mutabile, Escherichia fergusonii, Escherichia hermannii, Escherichia sp., Escherichia vul-
neris, Klebsiella aerogenes, Klebsiella edwardsii subsp. atlantae, Klebsiella ornithinolytica, Klebsiella oxytoca, Klebsiella
planticola, Klebsiella pneumoniae, Klebsiella pneumoniae subsp. pneumoniae, Klebsiella sp., Klebsiella terrigena, Kleb-
siella trevisanii, Salmonella abony, Salmonella arizonae, Salmonella bongori, Salmonella choleraesuis subsp. arizonae,
Salmonella choleraesuis subsp. bongori, Salmonella choleraesuis subsp. cholereasuis, Salmonella choleraesuis subsp.
diarizonae, Salmonella choleraesuis subsp. houtenae, Salmonella choleraesuis subsp. indica, Salmonella choleraesuis
subsp. salamae, Salmonella daressalaam, Salmonella enterica subsp. houtenae, Salmonella enterica subsp. salamae,
Salmonella enteritidis, Salmonella gallinarum, Salmonella heidelberg, Salmonella panama, Salmonella senftenberg,
Salmonella typhimurium, Serratia entomophila, Serratia ficaria, Serratia fonticola, Serratia grimesii, Serratia liquefaciens,
Serratia marcescens, Serratia marcescens subsp. marcescens, Serratia marinorubra, Serratia odorifera, Serratia ply-
mouthensis, Serratia plymuthica, Serratia proteamaculans, Serratia proteamaculans subsp. quinovora, Serratia quini-
vorans or Serratia rubidaea; Rhizobiaceae, such as the genera Agrobacterium, Carbophilus, Chelatobacter, Ensifer,
Rhizobium, Sinorhizobium, for example the genera and species Agrobacterium atlanticum, Agrobacterium ferrugineum,
Agrobacterium gelatinovorum, Agrobacterium larrymoorei, Agrobacterium meteori, Agrobacterium radiobacter, Agro-
bacterium rhizogenes, Agrobacterium rubi, Agrobacterium stellulatum, Agrobacterium tumefaciens, Agrobacterium vitis,
Carbophilus carboxidus, Chelatobacter heintzii, Ensifer adhaerens, Ensifer arboris, Ensifer fredii, Ensifer kostiensis,
Ensifer kummerowiae, Ensifer medicae, Ensifer meliloti, Ensifer saheli, Ensifer terangae, Ensifer xinjiangensis, Rhizo-
bium ciceri, Rhizobium etli, Rhizobium fredii, Rhizobium galegae, Rhizobium gallicum, Rhizobium giardinii, Rhizobium
hainanense, Rhizobium huakuii, Rhizobium huautlense, Rhizobium indigoferae, Rhizobium japonicum, Rhizobium le-
guminosarum, Rhizobium loessense, Rhizobium loti, Rhizobium lupini, Rhizobium mediterraneum, Rhizobium meliloti,
Rhizobium mongolense, Rhizobium phaseoli, Rhizobium radiobacter, Rhizobium rhizogenes, Rhizobium rubi, Rhizobium
sullae, Rhizobium tianshanense, Rhizobium trifolii, Rhizobium tropici, Rhizobium undicola, Rhizobium vitis, Sinorhizo-
bium adhaerens, Sinorhizobium arboris, Sinorhizobium fredii, Sinorhizobium kostiense, Sinorhizobium kummerowiae,
Sinorhizobium medicae, Sinorhizobium meliloti, Sinorhizobium morelense, Sinorhizobium saheli or Sinorhizobium xin-
jiangense.
[0054] Further utilizable host cells are detailed in: Goeddel, Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, CA (1990). Expression strains which can be used, for example those with a lower
protease activity, are described in: Gottesman, S., Gene Expression Technology: Methods in Enzymology 185, Academic
Press, San Diego, California (1990) 119-128. These include plant cells and certain tissues, organs and parts of plants
in all their phenotypic forms such as anthers, fibers, root hairs, stalks, embryos, calli, cotelydons, petioles, harvested
material, plant tissue, reproductive tissue and cell cultures which are derived from the actual transgenic plant and/or can
be used for bringing about the transgenic plant.
[0055] Polynucleotides or vectors can be introduced into the host cell as described above by means of transformation
or transfection methods which are known in the prior art. Conditions and media for the cultivation of the host cells are
also known to the skilled worker.
[0056] The host cell according to the invention preferably additionally comprises at least one further enzyme which is
involved in the biosynthesis of lipids or fatty acids. Preferred enzymes have already been mentioned in another place
in the description. The enzyme can be present in the host cell in endogenous form, i.e. the host cell already naturally
expresses a gene which codes for a corresponding enzyme. Alternatively, it is also possible to introduce, into the host
cell, a heterologous polynucleotide which codes for the enzyme. Suitable methods and means for the expression of a
heterologous polynucleotide are known in the prior art and are described herein in connection with the polynucleotides,
vectors and host cells according to the invention.
[0057] The invention also relates to a method of generating a polypeptide with desaturase activity, comprising the steps:
(a) expressing a polynucleotide according to the invention as defined above in a host cell; and
(b) obtaining, from the host cell, the polypeptide which is encoded by the polynucleotide.
[0058] In this context, the polypeptide can be obtained or isolated by all current protein purification methods. The
methods comprise, for example, affinity chromatography, molecular sieve chromatography, high-pressure liquid chro-
matography or else protein precipitation, if appropriate with specific antibodies. Although this is preferred, the method
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need not necessarily provide a pure polypeptide preparation.
[0059] The invention therefore also relates to a polypeptide which is encoded by the polynucleotide according to the
invention.
[0060] The term "polypeptide" refers both to an essentially pure polypeptide, and also to a polypeptide preparation
which additionally comprises further components or impurities. The term is also used for fusion proteins and protein
aggregates which comprise the polypeptide according to the invention and additionally further components. The term
also refers to chemically modified polypeptides. In this context, chemical modifications comprise artificial modifications
or naturally occurring modifications, for example posttranslational modifications such as phosphorylation, myristylation,
glycosylation and the like. The terms polypeptide, peptide and protein are interchangeable and are used accordingly in
the description and in the prior art. The polypeptides according to the invention have the abovementioned biological
activities, that is to say desaturase activities, and can influence the biosynthesis of polyunsaturated fatty acids (PUFAs),
preferably the long-chain PUFAs (LCPUFAs), as herein described.
[0061] The invention also comprises an antibody which specifically recognizes the polypeptide having an amino acid
sequence as shown in SEQ ID No. 2.
[0062] Antibodies against the polypeptide according to the invention can be prepared by means of known methods,
where purified polypeptide or fragments thereof with suitable epitopes are used as the antigen. Suitable epitopes can
be determined by means of known algorithms for the antigenicity determination, based on the amino acid sequences of
the polypeptides according to the invention provided herein. The relevant polypeptides or fragments can then be syn-
thesized or obtained by recombinant techniques. After animals, preferably mammals, for example hares, rats or mice,
have been immunized, the antibodies can then be obtained from the serum, using known methods. Alternatively, mon-
oclonal antibodies or antibody fragments can be provided with the known methods; see, for example, Harlow and Lane
"Antibodies, A Laboratory Manual", CSH Press, Cold Spring Harbor, 1988 or Köhler and Milstein, Nature 256 (1975),
495, and Galfré, Meth. Enzymol. 73 (1981), 3.
[0063] The antibodies preferably take the form of monoclonal or polyclonal antibodies, single-chain antibodies or
chimeric antibodies, and fragments of these such as Fab, Fv or scFv. Further antibodies within the meaning of the
invention are bispecific antibodies, synthetic antibodies or their chemically modified derivatives.
[0064] The antibodies according to the invention specifically recognize the polypeptides according to the invention,
that is to say they do not cross-react significantly with other proteins. This can be assayed by means of methods known
in the prior art. For example, the antibodies can be employed for the purposes of detection reactions, immunoprecipitation,
immunhistochemistry or protein purification (for example affinity chromatography).
[0065] The invention furthermore relates to a transgenic, nonhuman organism which comprises the polynucleotide,
the vector or the host cell of the present invention. The transgenic, nonhuman organism preferably takes the form of an
animal, a plant or a multicellular microorganism.
[0066] The term "transgenic" is understood as meaning that a heterologous polynucleotide, that is to say a polynucle-
otide which does not occur naturally in the respective organism, is introduced into the organism. This can be achieved
either by random insertion of the polynucleotide or by homologous recombination. Naturally, it is also possible to introduce
the vector according to the invention instead of the polynucleotide. Methods of introducing polynucleotides or vectors
for the purposes of random insertion or homologous recombination are known in the prior art and also described in
greater detail hereinbelow. Host cells which comprise the polynucleotide or the vector can also be introduced into an
organism and thus generate a transgenic organism. In such a case, such an organism takes the form of a chimeric
organism, where only those cells which are derived from the introduced cells are transgenic, i.e. comprise the heterologous
polynucleotide.
[0067] The transgenic nonhuman organisms are preferably oil-producing organisms, which means organisms which
are used for the production of oils, for example fungi such as Rhizopus or Thraustochytrium, algae such as Euglena,
Nephroselmis, Pseudoscourfielda, Prasinococcus, Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, Crypthecodin-
ium, Phaeodactylum, or diatoms such as Pythium or Phytophthora or plants.
[0068] Transgenic plants which can be used are, in principle, are all plants, that is to say both dicotyledonous and
monocotyledonous plants. They preferably take the form of oil crop plants which comprise large amounts of lipid com-
pounds, such as peanut, oilseed rape, canola, sunflower, safflower (Carthamus tinctoria), poppy, mustard, hemp, castor-
oil plant, olive, sesame, Calendula, Punica, evening primrose, verbascum, thistle, wild roses, hazelnut, almond, mac-
adamia, avocado, bay, pumpkin/squash, linseed, soybean, pistachios, borage, trees (oil palm, coconut or walnut) or
arable crops such as maize, wheat, rye, oats, triticale, rice, barley, cotton, cassava, pepper, Tagetes, Solanaceae plants
such as potato, tobacco, eggplant and tomato, Vicia species, pea, alfalfa or bushy plants (coffee, cacao, tea), Salix
species, and perennial grasses and fodder crops. Preferred plants according to the invention are oil crop plants such
as peanut, oilseed rape, canola, sunflower, safflower, poppy, mustard, hemp, castor-oil plant, olive, Calendula, Punica,
evening primrose, pumpkin/squash, linseed, soybean, borage, trees (oil palm, coconut). Especially preferred are plants
which are high in C18:2- and/or C18:3-fatty acids, such as sunflower, safflower, tobacco, verbascum, sesame, cotton,
pumpkin/squash, poppy, evening primrose, walnut, linseed, hemp, thistle or safflower. Very especially preferred plants
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are plants such as safflower, sunflower, poppy, evening primrose, walnut, linseed or hemp. In principle, however, all
plants which are capable of synthesizing fatty acids are suitable, such as all dicotyledonous or monocotyledonous plants,
algae or mosses. Advantageous plants are selected from the group of the plant families Adelotheciaceae, Anacardiaceae,
Asteraceae, Apiaceae, Betulaceae, Boraginaceae, Brassicaceae, Bromeliaceae, Caricaceae, Cannabaceae, Convol-
vulaceae, Chenopodiaceae, Crypthecodiniaceae, Cucurbitaceae, Ditrichaceae, Elaeagnaceae, Ericaceae, Euphor-
biaceae, Fabaceae, Geraniaceae, Gramineae, Juglandaceae, Lauraceae, Leguminosae, Linaceae, Prasinophyceae or
vegetable plants or ornamentals such as Tagetes.
[0069] Examples which may especially preferably be mentioned are the following plants selected from the group
consisting of: Adelotheciaceae such as the genera Physcomitrella, for example the genus and species Physcomitrella
patens, Anacardiaceae such as the genera Pistacia, Mangifera, Anacardium, for example the genus and species Pistacia
vera [pistachio], Mangifer indica [mango] or Anacardium occidentale [cashew], Asteraceae, such as the genera Calen-
dula, Carthamus, Centaurea, Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes, Valeriana, for example the
genus and species Calendula officinalis [common marigold], Carthamus tinctorius [safflower], Centaurea cyanus [corn-
flower], Cichorium intybus [chicory], Cynara scolymus [artichoke], Helianthus annus [sunflower], Lactuca sativa, Lactuca
crispa, Lactuca esculenta, Lactuca scariola L. ssp. sativa, Lactuca scariola L. var. integrata, Lactuca scariola L. var.
integrifolia, Lactuca sativa subsp. romana, Locusta communis, Valeriana locusta [salad vegetables], Tagetes lucida,
Tagetes erecta or Tagetes tenuifolia [african or french marigold], Apiaceae, such as the genus Daucus, for example the
genus and species Daucus carota [carrot], Betulaceae, such as the genus Corylus, for example the genera and species
Corylus avellana or Corylus colurna [hazelnut], Boraginaceae, such as the genus Borago, for example the genus and
species Borago officinalis [borage], Brassicaceae, such as the genera Brassica, Camelina, Melanosinapis, Sinapis,
Arabadopsis, for example the genera and species Brassica napus, Brassica rapa ssp. [oilseed rape], Sinapis arvensis
Brassica juncea, Brassica juncea var. juncea, Brassica juncea var. crispifolia, Brassica juncea var. foliosa, Brassica
nigra, Brassica sinapioides, Camelina sativa, Melanosinapis communis [mustard], Brassica oleracea [fodder beet] or
Arabadopsis thaliana, Bromeliaceae, such as the genera Anana, Bromelia (pineapple), for example the genera and
species Anana comosus, Ananas ananas or Bromelia comosa [pineapple], Caricaceae, such as the genus Carica, such
as the genus and species Carica papaya [pawpaw], Cannabaceae, such as the genus Cannabis, such as the genus
and species Cannabis sative [hemp], Convolvulaceae, such as the genera Ipomea, Convolvulus, for example the genera
and species Ipomoea batatus, Ipomoea pandurata, Convolvulus batatas, Convolvulus tiliaceus, Ipomoea fastigiata,
Ipomoea tiliacea, Ipomoea triloba or Convolvulus panduratus [sweet potato, batate], Chenopodiaceae, such as the genus
Beta, such as the genera and species Beta vulgaris, Beta vulgaris var. altissima, Beta vulgaris var. vulgaris, Beta
maritima, Beta vulgaris var. perennis, Beta vulgaris var. conditiva or Beta vulgaris var. esculenta [sugarbeet], Crypthe-
codiniaceae, such as the genus Crypthecodinium, for example the genus and species Cryptecodinium cohnii, Cucur-
bitaceae, such as the genus Cucurbita, for example the genera and species Cucurbita maxima, Cucurbita mixta, Cucurbita
pepo or Cucurbita moschata [pumpkin/squash], Cymbellaceae, such as the genera Amphora, Cymbella, Okedenia,
Phaeodactylum, Reimeria, for example the genus and species Phaeodactylum tricornutum, Ditrichaceae, such as the
genera Ditrichaceae, Astomiopsis, Ceratodon, Chrysoblastella, Ditrichum, Distichium, Eccremidium, Lophidion, Philib-
ertiella, Pleuridium, Saelania, Trichodon, Skottsbergia, for example the genera and species Ceratodon antarcticus,
Ceratodon columbiae, Ceratodon heterophyllus, Ceratodon purpurascens, Ceratodon purpureus, Ceratodon purpureus
ssp. convolutus, Ceratodon purpureus ssp. stenocarpus, Ceratodon purpureus var. rotundifolius, Ceratodon ratodon,
Ceratodon stenocarpus, Chrysoblastella chilensis, Ditrichum ambiguum, Ditrichum brevisetum, Ditrichum crispatissi-
mum, Ditrichum difficile, Ditrichum falcifolium, Ditrichum flexicaule, Ditrichum giganteum, Ditrichum heteromallum, Ditri-
chum lineare, Ditrichum montanum, Ditrichum montanum, Ditrichum pallidum, Ditrichum punctulatum, Ditrichum pusillum,
Ditrichum pusillum var. tortile, Ditrichum rhynchostegium, Ditrichum schimperi, Ditrichum tortile, Distichium capillaceum,
Distichium hagenii, Distichium inclinatum, Distichium macounii, Eccremidium floridanum, Eccremidium whiteleggei, Lo-
phidion strictus, Pleuridium acuminatum, Pleuridium alternifolium, Pleuridium holdridgei, Pleuridium mexicanum, Pleu-
ridium ravenelii, Pleuridium subulatum, Saelania glaucescens, Trichodon borealis, Trichodon cylindricus or Trichodon
cylindricus var. oblongus, Elaeagnaceae, such as the genus Elaeagnus, for example the genus and species Olea
europaea [olive], Ericaceae, such as the genus Kalmia, for example the genera and species Kalmia latifolia, Kalmia
angustifolia, Kalmia microphylla, Kalmia polifolia, Kalmia occidentalis, Cistus chamaerhodendros or Kalmia lucida [moun-
tain laurel], Euphorbiaceae, such as the genera Manihot, Janipha, Jatropha, Ricinus, for example the genera and species
Manihot utilissima, Janipha manihot, Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot manihot, Manihot melano-
basis, Manihot esculenta [cassava] or Ricinus communis [castor-oil plant], Fabaceae, such as the genera Pisum, Albizia,
Cathormion, Feuillea, Inga, Pithecolobium, Acacia, Mimosa, Medicajo, Glycine, Dolichos, Phaseolus, soybean, for ex-
ample the genera and species Pisum sativum, Pisum arvense, Pisum humile [pea], Albizia berteriana, Albizia julibrissin,
Albizia lebbeck, Acacia berteriana, Acacia littoralis, Albizia berteriana, Albizzia berteriana, Cathormion berteriana, Feuil-
lea berteriana, Inga fragrans, Pithecellobium berterianum, Pithecellobium fragrans, Pithecolobium berterianum, Pseu-
dalbizzia berteriana, Acacia julibrissin, Acacia nemu, Albizia nemu, Feuilleea julibrissin, Mimosa julibrissin, Mimosa
speciosa, Sericanrda julibrissin, Acacia lebbeck, Acacia macrophylla, Albizia lebbeck, Feuilleea lebbeck, Mimosa leb-
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beck, Mimosa speciosa [silk tree], Medicago sativa, Medicago falcata, Medicago varia [alfalfa] Glycine max Dolichos
soja, Glycine gracilis, Glycine hispida, Phaseolus max, Soja hispida or Soja max [soybean], Funariaceae, such as the
genera Aphanorrhegma, Entosthodon, Funaria, Physcomitrella, Physcomitrium, for example the genera and species
Aphanorrhegma serratum, Entosthodon attenuatus, Entosthodon bolanderi, Entosthodon bonplandii, Entosthodon cal-
ifornicus, Entosthodon drummondii, Entosthodon jamesonii, Entosthodon leibergii, Entosthodon neoscoticus, Entostho-
don rubrisetus, Entosthodon spathulifolius, Entosthodon tucsoni, Funaria americana, Funaria bolanderi, Funaria calca-
rea, Funaria californica, Funaria calvescens, Funaria convoluta, Funaria flavicans, Funaria groutiana, Funaria hygro-
metrica, Funaria hygrometrica var. arctica, Funaria hygrometrica var. calvescens, Funaria hygrometrica var. convoluta,
Funaria hygrometrica var. muralis, Funaria hygrometrica var. utahensis, Funaria microstoma, Funaria microstoma var.
obtusifolia, Funaria muhlenbergii, Funaria orcuttii, Funaria plano-convexa, Funaria polaris, Funaria ravenelii, Funaria
rubriseta, Funaria serrata, Funaria sonorae, Funaria sublimbatus, Funaria tucsoni, Physcomitrella californica, Phys-
comitrella patens, Physcomitrella readeri, Physcomitrium australe, Physcomitrium californicum, Physcomitrium collen-
chymatum, Physcomitrium coloradense, Physcomitrium cupuliferum, Physcomitrium drummondii, Physcomitrium eurys-
tomum, Physcomitrium flexifolium, Physcomitrium hookeri, Physcomitrium hookeri var. serratum, Physcomitrium immer-
sum, Physcomitrium kellermanii, Physcomitrium megalocarpum, Physcomitrium pyriforme, Physcomitrium pyriforme
var. serratum, Physcomitrium rufipes, Physcomitrium sandbergii, Physcomitrium subsphaericum, Physcomitrium wash-
ingtoniense, Geraniaceae, such as the genera Pelargonium, Cocos, Oleum, for example the genera and species Cocos
nucifera, Pelargonium grossularioides or Oleum cocois [coconut], Gramineae, such as the genus Saccharum, for example
the genus and species Saccharum officinarum, Juglandaceae, such as the genera Juglans, Wallia, for example the
genera and species Juglans regia, Juglans ailanthifolia, Juglans sieboldiana, Juglans cinerea, Wallia cinerea, Juglans
bixbyi, Juglans californica, Juglans hindsii, Juglans intermedia, Juglans jamaicensis, Juglans major, Juglans microcarpa,
Juglans nigra or Wallia nigra [walnut], Lauraceae, such as the genera Persea, Laurus, for example the genera and
species Laurus nobilis [bay], Persea americana, Persea gratissima or Persea persea [avocado], Leguminosae, such as
the genus Arachis, for example the genus and species Arachis hypogaea [peanut], Linaceae, such as the genera Linum,
Adenolinum, for example the genera and species Linum usitatissimum, Linum humile, Linum austriacum, Linum bienne,
Linum angustifolium, Linum catharticum, Linum flavum, Linum grandiflorum, Adenolinum grandiflorum, Linum lewisii,
Linum narbonense, Linum perenne, Linum perenne var. lewisii, Linum pratense or Linum trigynum [linseed], Lythrarieae,
such as the genus Punica, for example the genus and species Punica granatum [pomegranate], Malvaceae, such as
the genus Gossypium, for example the genera and species Gossypium hirsutum, Gossypium arboreum, Gossypium
barbadense, Gossypium herbaceum or Gossypium thurberi [cotton], Marchantiaceae, such as the genus Marchantia,
for example the genera and species Marchantia berteroana, Marchantia foliacea, Marchantia macropora, Musaceae,
such as the genus Musa, for example the genera and species Musa nana, Musa acuminata, Musa paradisiaca, Musa
spp. [banana], Onagraceae, such as the genera Camissonia, Oenothera, for example the genera and species Oenothera
biennis or Camissonia brevipes [evening primrose], Palmae, such as the genus Elacis, for example the genus and
species Elaeis guineensis [oil palm], Papaveraceae, such as the genus Papaver, for example the genera and species
Papaver orientale, Papaver rhoeas, Papaver dubium [poppy], Pedaliaceae, such as the genus Sesamum, for example
the genus and species Sesamum indicum [sesame], Piperaceae, such as the genera Piper, Artanthe, Peperomia,
Steffensia, for example the genera and species Piper aduncum, Piper amalago, Piper angustifolium, Piper auritum,
Piper betel, Piper cubeba, Piper longum, Piper nigrum, Piper retrofractum, Artanthe adunca, Artanthe elongata, Peper-
omia elongata, Piper elongatum, Steffensia elongata [cayenne pepper], Poaceae, such as the genera Hordeum, Secale,
Avena, Sorghum, Andropogon, Holcus, Panicum, Oryza, Zea (maize), Triticum, for example the genera and species
Hordeum vulgare, Hordeum jubatum, Hordeum murinum, Hordeum secalinum, Hordeum distichon, Hordeum aegiceras,
Hordeum hexastichon, Hordeum hexastichum, Hordeum irregulare, Hordeum sativum, Hordeum secalinum [barley],
Secale cereale [rye], Avena sativa, Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida [oats], Sorghum
bicolor, Sorghum halepense, Sorghum saccharatum, Sorghum vulgare, Andropogon drummondii, Holcus bicolor, Holcus
sorghum, Sorghum aethiopicum, Sorghum arundinaceum, Sorghum caffrorum, Sorghum cernuum, Sorghum dochna,
Sorghum drummondii, Sorghum durra, Sorghum guineense, Sorghum lanceolatum, Sorghum nervosum, Sorghum sac-
charatum, Sorghum subglabrescens, Sorghum verticilliflorum, Sorghum vulgare, Holcus halepensis, Sorghum mil-
iaceum, Panicum militaceum [millet], Oryza sativa, Oryza latifolia [rice], Zea mays [maize] Triticum aestivum, Triticum
durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum or Triticum vulgare [wheat], Porphyrid-
iaceae, such as the genera Chroothece, Flintiella, Petrovanella, Porphyridium, Rhodella, Rhodosorus, Vanhoeffenia,
for example the genus and species Porphyridium cruentum, Proteaceae, such as the genus Macadamia, for example
the genus and species Macadamia intergrifolia [macadamia], Prasinophyceae, such as the genera Nephroselmis, Pra-
sinococcus, Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, for example the genera and species Nephroselmis
olivacea, Prasinococcus capsulatus, Scherffelia dubia, Tetraselmis chui, Tetraselmis suecica, Mantoniella squamata,
Ostreococcus tauri, Rubiaceae, such as the genus Coffea, for example the genera and species Cofea spp., Coffea
arabica, Coffea canephora or Coffea liberica [coffee], Scrophulariaceae, such as the genus Verbascum, for example
the genera and species Verbascum blattaria, Verbascum chaixii, Verbascum densiflorum, Verbascum lagurus, Verbas-
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cum longifolium, Verbascum lychnitis, Verbascum nigrum, Verbascum olympicum, Venbascum phlomoides, Verbascum
phoenicum, Verbascum pulverulentum or Verbascum thapsus [verbascum], Solanaceae, such as the genera Capsicum,
Nicotiana, Solanum, Lycopersicon, for example the genera and species Capsicum annuum, Capsicum annuum var.
glabriusculum, Capsicum frutescens [pepper], Capsicum annuum [paprika], Nicotiana tabacum, Nicotiana alata, Nico-
tiana attenuata, Nicotiana glauca, Nicotiana langsdorffii, Nicotiana obtusifolia, Nicotiana quadrivalvis, Nicotiana repanda,
Nicotiana rustica, Nicotiana sylvestris [tobacco], Solanum tuberosum [potato], Solanum melongena [eggplant], Lycop-
ersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme, Solanum integrifolium or Solanum lycopersi-
cum [tomato], Sterculiaceae, such as the genus Theobroma, for example the genus and species Theobroma cacao
[cacao] or Theaceae, such as the genus Camellia, for example the genus and species Camellia sinensis [tea].
[0070] Multicellular microorganisms which can be employed as transgenic nonhuman organisms are preferably protists
or diatoms selected from the group of the families Dinophyceae, Turaniellidae or Oxytrichidae, such as the genera and
species: Crypthecodinium cohnii, Phaeodactylum tricornutum, Stylonychia mytilus, Stylonychia pustulata, Stylonychia
putrina, Stylonychia notophora, Stylonychia sp., Colpidium campylum or Colpidium sp.
[0071] The invention further relates to a method for the production of a substance which has the structure shown in
the general formula I hereinbelow
where the variables and substituents are as follows:
R1 = hydroxyl, coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylg-
lycerol, lysodiphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol, sphingo base or a radical
of the formula II
R2 = hydrogen, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysodiphosphati-
dylglycerol, lysophosphatidylserine, lysophosphatidylinositol or saturated or unsaturated C2-C24-alkylcarbonyl,
R3 = hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl, or R2 and R3 independently of one another are a
radical of the formula Ia:
in which
n = 2, 3, 4, 5, 6, 7 or 9, m = 2, 3, 4, 5 or 6 and p = 0 or 3.
and where the method comprises the cultivation of (i) a host cell according to the invention or (ii) a transgenic nonhuman
organism according to the invention under conditions which permit the biosynthesis of the substance. Preferably, the
abovementioned substance is provided in an amount of at least 1% by weight based on the total lipid content in the host
cell or the transgenic organism.
[0072] R1 in the general formula I is hydroxyl, coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidyleth-
anolamine, lysophosphatidylglycerol, lysodiphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol,
EP 2 281 051 B1
19
5
10
15
20
25
30
35
40
45
50
55
sphingo base or a radical of the general formula II
[0073] The abovementioned radicals of R1 are always bonded to the compounds of the general formula I in the form
of their thioesters.
[0074] R2 in the general formula II is hydrogen, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophos-
phatidylglycerol, lysodiphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol or saturated or unsaturat-
ed C2-C24-alkylcarbonyl.
[0075] Alkyl radicals which may be mentioned are substituted or unsubstituted, saturated or unsaturated C2-C24-alkyl-
carbonyl chains such as ethylcarbonyl, n-propylcarbonyl, n-butylcarbonyl, n-pentylcarbonyl, n-hexylcarbonyl, n-heptyl-
carbonyl, n-octylcarbonyl, n-nonylcarbonyl, n-decylcarbonyl, n-undecylcarbonyl, n-dodecylcarbonyl, n-tridecylcarbonyl,
n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl, n-heptadecylcarbonyl, n-octadecylcarbonyl, n-nona-
decylcarbonyl, n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetracosanylcarbonyl, which comprise one or more double
bonds. Saturated or unsaturated C10-C22-alkylcarbonyl radicals such as n-decylcarbonyl, n-undecylcarbonyl, n-dodecyl-
carbonyl, n-tridecylcarbonyl, n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl, n-heptadecylcarbonyl,
n-octadecylcarbonyl, n-nonadecylcarbonyl, n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetracosanylcarbonyl, which
comprise one or more double bonds are preferred. Especially preferred are saturated and/or unsaturated C10-C22-alkyl-
carbonyl radicals such as C10-alkylcarbonyl, C11-alkylcarbonyl, C12-alkylcarbonyl, C13-alkylcarbonyl, C14-alkylcarbonyl,
C16-alkylcarbonyl, C18-alkylcarbonyl, C20-alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double
bonds. Very especially preferred are saturated or unsaturated C16-C22-alkylcarbonyl radicals such as C16-alkylcarbonyl,
C18-alkylcarbonyl, C20-alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double bonds. These
advantageous radicals can comprise two, three, four, five or six double bonds. The especially advantageous radicals
with 20 or 22 carbon atoms in the fatty acid chain comprise up to six double bonds, advantageously three, four, five or
six double bonds, especially preferably five or six double bonds. All the abovementioned radicals are derived from the
corresponding fatty acids.
[0076] R3 in the general formula II is hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl.
[0077] Alkyl radicals which may be mentioned are substituted or unsubstituted, saturated or unsaturated C2-C24-alkyl-
carbonyl chains such as ethylcarbonyl, n-propylcarbonyl, n-butylcarbonyl, n-pentylcarbonyl, n-hexylcarbonyl, n-heptyl-
carbonyl, n-octylcarbonyl, n-nonylcarbonyl, n-decylcarbonyl, n-undecylcarbonyl, n-dodecylcarbonyl, n-tridecylcarbonyl,
n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl, n-heptadecylcarbonyl, n-octadecylcarbonyl-, n-non-
adecylcarbonyl, n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetracosanylcarbonyl, which comprise one or more double
bonds. Saturated or unsaturated C10-C22-alkylcarbonyl radicals such as n-decylcarbonyl, n-undecylcarbonyl, n-dodecyl-
carbonyl, n-tridecylcarbonyl, n-tetradecylcarbonyl, n-pentadecylcarbonyl, n-hexadecylcarbonyl, n-heptadecylcarbonyl,
n-octadecylcarbonyl, n-nonadecylcarbonyl, n-eicosylcarbonyl, n-docosanylcarbonyl or n-tetracosanylcarbonyl, which
comprise one or more double bonds are preferred. Especially preferred are saturated and/or unsaturated C10-C22-alkyl-
carbonyl radicals such as C10-alkylcarbonyl, C11-alkylcarbonyl, C12-alkylcarbonyl, C13-alkylcarbonyl, C14-alkylcarbonyl,
C16-alkylcarbonyl, C18-alkylcarbonyl, C20-alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double
bonds. Very especially preferred are saturated or unsaturated C16-C22-alkylcarbonyl radicals such as C16-alkylcarbonyl,
C18-alkylcarbonyl, C20-alkylcarbonyl or C22-alkylcarbonyl radicals which comprise one or more double bonds. These
advantageous radicals can comprise two, three, four, five or six double bonds. The especially advantageous radicals
with 20 or 22 carbon atoms in the fatty acid chain comprise up to six double bonds, advantageously three, four, five or
six double bonds, especially preferably five or six double bonds. All the abovementioned radicals are derived from the
corresponding fatty acids.
[0078] The abovementioned radicals of R1, R2 and R3 can be substituted by hydroxyl and/or epoxy groups and/or can
comprise triple bonds.
[0079] The polyunsaturated fatty acids produced in the method according to the invention advantageously comprise
at least two, advantageously three, four, five or six, double bonds. The fatty acids especially advantageously comprise
four, five or six double bonds. Fatty acids produced in the method advantageously have 18, 20 or 22 C atoms in the
fatty acid chain; the fatty acids preferably comprise 20 or 22 carbon atoms in the fatty acid chain. Saturated fatty acids
are advantageously reacted to a minor degree, or not at all, with the nucleic acids used in the method. To a minor degree
is to be understood as meaning that the saturated fatty acids are reacted with less than 5% of the activity, advantageously
less than 3%, especially advantageously with less than 2%, very especially preferably with less than 1, 0.5, 0.25 or
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0.125% in comparison with polyunsaturated fatty acids. These fatty acids which have been produced can be produced
in the method as a single product or be present in a fatty acid mixture.
[0080] Advantageously, the substituents R2 or R3 in the general formulae I and II are, independently of one another,
saturated or unsaturated C18-C22-alkylcarbonyl, especially advantageously, they are, independently of one another,
unsaturated C18-, C20- or C22-alkylcarbonyl with at least two double bonds.
[0081] The polyunsaturated fatty acids produced in the method are advantageously bound in membrane lipids and/or
triacylglycerides, but may also occur in the organisms as free fatty acids or else bound in the form of other fatty acid
esters. In this context, they may be present as "pure products" or else advantageously in the form of mixtures of various
fatty acids or mixtures of different glycerides. The various fatty acids which are bound in the triacylglycerides can be
derived from short-chain fatty acids with 4 to 6 C atoms, medium-chain fatty acids with 8 to 12 C atoms or long-chain
fatty acids with 14 to 24 C atoms; preferred are long-chain fatty acids, more preferably long-chain polyunsaturated fatty
acids with 18, 20 and/or 22 C atoms.
[0082] The method according to the invention advantageously yields fatty acid esters with polyunsaturated C18-, C20-
and/or C22-fatty acid molecules with at least two double bonds in the fatty acid ester, advantageously with at least three,
four, five or six double bonds in the fatty acid ester, especially advantageously with at least five or six double bonds in
the fatty acid ester and advantageously leads to the synthesis of linoleic acid (=LA, C18:2Δ9,12), y-linolenic acid (= GLA,
C18:3Δ6,9,12), stearidonic acid (= SDA, C18:4Δ6,9,12,15), dihomo-y-linolenic acid (= DGLA, 20:3Δ8,11,14), ω3-eicosatetrae-
noic acid (= ETA, C20:4 Δ5,8,11,14), arachidonic acid (ARA, C20:4 Δ5,8,11,14), eicosapentaenoic acid (E P A ,
C20:5Δ5,8,11,14,17), ω6-docosapentaenoic acid (C22:5Δ4,7,10,13,16), ω6-docosatetraenoic acid (C22:4Δ7,10,13,16), ω3-do-
cosapentaenoic acid (= DPA, C22:5Δ7,10,13,16,19), docosahexaenoic acid (= DHA, C22:6Δ4,7,10,13,16,19) or mixtures of
these, preferably ARA, EPA and/or DHA. ω3-Fatty acids such as EPA and/or DHA are very especially preferably produced.
[0083] The fatty acid esters with polyunsaturated C18-, C20- and/or C22-fatty acid molecules can be isolated in the
form of an oil or lipid, for example in the form of compounds such as sphingolipids, phosphoglycerides, lipids, glycolipids
such as glycosphingolipids, phospholipids such as phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine,
phosphatidylglycerol, phosphatidylinositol or diphosphatidylglycerol, monoacylglycerides, diacylglycerides, triacylglyc-
erides or other fatty acid esters such as the acetyl-coenzyme A esters which comprise the polyunsaturated fatty acids
with at least two, three, four, five or six, preferably five or six double bonds, from the organisms which have been used
for the preparation of the fatty acid esters; advantageously, they are isolated in the form of their diacylglycerides, tria-
cylglycerides and/or in the form of phosphatidylcholine, especially preferably in the form of the triacylglycerides. In
addition to these esters, the polyunsaturated fatty acids are also present in the organisms, advantageously the plants,
as free fatty acids or bound in other compounds. As a rule, the various abovementioned compounds (fatty acid esters
and free fatty acids) are present in the organisms with an approximate distribution of 80 to 90% by weight of triglycerides,
2 to 5% by weight of diglycerides, 5 to 10% by weight of monoglycerides, 1 to 5% by weight of free fatty acids, 2 to 8%
by weight of phospholipids, the total of the various compounds amounting to 100% by weight.
[0084] The method according to the invention yields the LCPUFAs produced in a content of at least 3% by weight,
advantageously at least 5% by weight, preferably at least 8% by weight, especially preferably at least 10% by weight,
most preferably at least 15% by weight, based on the total fatty acids in the transgenic organisms, advantageously in a
transgenic plant. In this context, it is advantageous to convert C18- and/or C20-fatty acids which are present in the host
organisms to at least 10%, advantageously to at least 20%, especially advantageously to at least 30%, most advanta-
geously to at least 40% to give the corresponding products such as DPA or DHA, to mention just two examples. The
fatty acids are advantageously produced in bound form. These unsaturated fatty acids can, with the aid of the nucleic
acids used in the method according to the invention, be positioned at the sn1, sn2 and/or sn3 position of the advanta-
geously produced triglycerides. Since a plurality of reaction steps are performed by the starting compounds linoleic acid
(C18:2) and linolenic acid (C18:3) in the method according to the invention, the end products of the method such as, for
example, arachidonic acid (ARA), eicosapentaenoic acid (EPA), ω6-docosapentaenoic acid or DHA are not obtained
as absolutely pure products; minor traces of the precursors are always present in the end product. If, for example, both
linoleic acid and linolenic acid are present in the starting organism and the starting plant, the end products such as ARA,
EPA or DHA are present as mixtures. The precursors should advantageously not amount to more than 20% by weight,
preferably not to more than 15% by weight, especially preferably not to more than 10% by weight, most preferably not
to more than 5% by weight, based on the amount of the end product in question. Advantageously, only ARA, EPA or
only DHA, bound or as free acids, are produced as end products in a transgenic plant in the method according to the
invention. If the compounds ARA, EPA and DHA are produced simultaneously, they are advantageously produced in a
ratio of at least 1:1:2 (EPA:ARA:DHA), advantageously of at least 1:1:3, preferably 1:1:4, especially preferably 1:1:5.
[0085] Fatty acid esters or fatty acid mixtures produced by the method according to the invention advantageously
comprise 6 to 15% of palmitic acid, 1 to 6% of stearic acid, 7-85% of oleic acid, 0.5 to 8% of vaccenic acid, 0.1 to 1%
of arachic acid, 7 to 25% of saturated fatty acids, 8 to 85% of monounsaturated fatty acids and 60 to 85% of polyunsaturated
fatty acids, in each case based on 100% and on the total fatty acid content of the organisms. Advantageous polyunsat-
urated fatty acids which are present in the fatty acid esters or fatty acid mixtures are preferably at least 0.1, 0.2, 0.3,
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0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1% of arachidonic acid, based on the total fatty acid content. Moreover, the fatty acid esters
or fatty acid mixtures which have been produced by the method of the invention advantageously comprise fatty acids
selected from the group of the fatty acids erucic acid (13-docosaenoic acid), sterculic acid (9,10-methyleneoctadec-9-
enoic acid), malvalic acid (8,9-methyleneheptadec-8-enoic acid), chaulmoogric acid (cyclopentenedodecanoic acid),
furan fatty acid (9,12-epoxyoctadeca-9,11-dienoic acid), vernolic acid (9,10-epoxyoctadec-12-enoic acid), tarinic acid
(6-octadecynoic acid), 6-nonadecynoic acid, santalbic acid (t11-octadecen-9-ynoic acid), 6,9-octadecenynoic acid, pyru-
lic acid (t10-heptadecen-8-ynoic acid), crepenynic acid (9-octadecen-12-ynoic acid), 13,14-dihydrooropheic acid, octa-
decen-13-ene-9,11-diynoic acid, petroselenic acid (cis-6-octadecenoic acid), 9c,12t-octadecadienoic acid, calendulic
acid (8t10t12c-octadecatrienoic acid), catalpic acid (9t11t13c-octadecatrienoic acid), eleostearic acid (9c11t13t-octade-
catrienoic acid), jacaric acid (8c10t12c-octadecatrienoic acid), punicic acid (9c11t13c-octadecatrienoic acid), parinaric
acid (9c11t13t15c-octadecatetraenoic acid), pinolenic acid (all-cis-5,9,12-octadecatrienoic acid), laballenic acid (5,6-
octadecadienallenic acid), ricinoleic acid (12-hydroxyoleic acid) and/or coriolic acid (13-hydroxy-9c,11t-octadecadienoic
acid). The abovementioned fatty acids are, as a rule, advantageously only found in traces in the fatty acid esters or fatty
acid mixtures produced by the method according to the invention, that is to say that, based on the total fatty acids, they
occur to less than 30%, preferably to less than 25%, 24%, 23%, 22% or 21%, especially preferably to less than 20%,
15%, 10%, 9%, 8%, 7%, 6% or 5%, very especially preferably to less than 4%, 3%, 2% or 1%. The fatty acid esters or
fatty acid mixtures produced by the method according to the invention advantageously comprise less than 0.1%, based
on the total fatty acids, or no butyric acid, no cholesterol, no clupanodonic acid (= docosapentaenoic acid,
C22:5Δ48,12,11,21) and no nisinic acid (tetracosahexaenoic acid, C23:6Δ3,8,12,15,18,21). Owing to the nucleic acid sequences
of the invention, or the nucleic acid sequences used in the method according to the invention, an increase in the yield
of polyunsaturated fatty acids of at least 50%, advantageously of at least 80%, especially advantageously of at least
100%, very especially advantageously of at least 150%, in comparison with the nontransgenic starting organism, for
example a yeast, an alga, a fungus or a plant such as Arabidopsis or linseed can be obtained in a comparison by GC
analysis.
[0086] Chemically pure polyunsaturated fatty acids or fatty acid compositions can also be prepared by the methods
described above. To this end, the fatty acids or the fatty acid compositions are isolated from the organism, such as the
microorganisms or the plants or the culture medium in or on which the organisms have been grown, or from the organism
and the culture medium, in a known manner, for example via extraction, distillation, crystallization, chromatography or
combinations of these methods. These chemically pure fatty acids or fatty acid compositions are advantageous for
applications in the food industry sector, the cosmetic industry sector and especially the pharmacological industry sector.
[0087] In principle, all genes of the fatty acid or lipid metabolism can be used in the method for the production of
polyunsaturated fatty acids, advantageously in combination with the inventive polynucleotide(s) (for the purposes of the
present application, the plural is understood as encompassing the singular and vice versa). Genes of the fatty acid or
lipid metabolism which are used are advantageously selected from the group consisting of acyl-CoA dehydrogenase(s),
acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty acid acyltransferase(s), acyl-CoA:lyso-
phospholipid acyltransferases, fatty acid synthase(s), fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-
coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acetylenases, lipoxygenases, triacylglycerol lipases, allene
oxide synthases, hydroperoxide lyases or fatty acid elongase(s). Genes selected from the group of the Δ4-desaturases,
Δ5-desaturases, Δ6-desaturases, Δ8-desaturases, Δ9-desaturases, Δ12-desaturases, Δ15-desaturases, Δ12- and Δ15-
desaturases, ω3-desaturases, Δ6-elongases, Δ9-elongases or Δ5-elongases in combination with the polynucleotides
according to the invention are preferably used, it being possible to use individual genes or a plurality of genes in com-
bination. For especially preferred gene combinations, reference is made here to tables 5 and 6, which are shown in the
examples.
[0088] Advantageously, the desaturases used in the method according to the invention convert their respective sub-
strates in the form of the CoA-fatty acid esters. If preceded by an elongation step, this advantageously results in an
increased product yield. The respective desaturation products are thereby synthesized in greater quantities, since the
elongation step is usually carried out with the CoA-fatty acid esters, while the desaturation step is predominantly carried
out with the phospholipids or the triglycerides. Therefore, a substitution reaction between the CoA-fatty acid esters and
the phospholipids or triglycerides, which would require a further, possibly limiting, enzyme reaction, is not necessary.
[0089] Owing to the enzymatic activity of the polypeptides used in the method according to the invention, a wide range
of polyunsaturated fatty acids can be produced in the method according to the invention. Depending on the choice of
the organisms, such as the advantageous plants, used for the method according to the invention, mixtures of the various
polyunsaturated fatty acids or individual polyunsaturated fatty acids, such as EPA or ARA, can be produced in free or
bound form. Depending on the prevailing fatty acid composition in the starting plant (C18:2- or C18:3-fatty acids), fatty
acids which are derived from C18:2-fatty acids, such as GLA, DGLA or ARA, or fatty acids which are derived from C18:3-
fatty acids, such as SDA, ETA or EPA, are thus obtained. If only linoleic acid (= LA, C18:2Δ9,12) is present as unsaturated
fatty acid in the plant used for the method, the method can only afford GLA, DGLA and ARA as products, all of which
can be present as free fatty acids or in bound form. If only α-linolenic acid (= ALA, C18:3Δ9,12,15) is present as unsaturated
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fatty acid in the plant used for the method, the method can only afford SDA, ETA, EPA and/or DHA as products, all of
which can be present as free fatty acids or in bound form, as described above. Owing to the modification of the activity
of the enzymes Δ5-desaturase, Δ6-desaturase, Δ4-desaturase, Δ12-desaturase, Δ15-desaturase, ω3-desaturase, Δ5-
elongase and/or Δ6-elongase which play a role in the synthesis, it is possible to produce, in a targeted fashion, only
individual products in the abovementioned organisms, advantageously in the abovementioned plants. Owing to the
activity of Δ6-desaturase and Δ6-elongase, for example, GLA and DGLA, or SDA and ETA, are formed, depending on
the starting plant and unsaturated fatty acid. DGLA or ETA or mixtures of these are preferably formed. If Δ5-desaturase,
Δ5-elongase and Δ4-desaturase are additionally introduced into the organisms, advantageously into the plant, ARA,
EPA and/or DHA are additionally formed. Advantageously, only ARA, EPA or DHA or mixtures of these are synthesized,
depending on the fatty acids present in the organism, or in the plant, which acts as starting substance for the synthesis.
Since biosynthetic cascades are involved, the end products in question are not present as pure substances in the
organisms. Small amounts of the precursor compounds are always additionally present in the end product. These small
amounts amount to less than 20% by weight, advantageously less than 15% by weight, especially advantageously less
than 10% by weight, most advantageously less than 5, 4, 3, 2 or 1% by weight, based on the end product DGLA, ETA
or their mixtures, or ARA, EPA, DHA or their mixtures, advantageously EPA or DHA or their mixtures.
[0090] In addition to the production, directly in the organism, of the starting fatty acids for the polypeptides used in the
method of the invention, the fatty acids can also be fed externally. The production in the organism is preferred for reasons
of economy. Preferred substrates are linoleic acid (C18:2Δ9,12), y-linolenic acid (C18:3Δ6,9,12), eicosadienoic acid
(C20:2Δ11,14), dihomo-y-linolenic acid (C20:3Δ8,11,14), arachidonic acid (C20:4Δ5,8,11,14), docosatetraenoic acid
(C22:4Δ7,10,13,16) and docosapentaenoic acid (C22:5Δ4,7,10,13,15).
[0091] To increase the yield in the described method for the production of oils and/or triglycerides with an advanta-
geously elevated content of polyunsaturated fatty acids, it is advantageous to increase the amount of starting product
for the synthesis of fatty acids; this can be achieved for example by introducing, into the organism, a nucleic acid which
codes for a polypeptide with a Δ5-desaturase activity according to the invention. This is particularly advantageous in oil-
producing organisms such as those from the family of the Brassicaceae, such as the genus Brassica, for example oilseed
rape; the family of the Elaeagnaceae, such as the genus Elaeagnus, for example the genus and species Olea europaea,
or the family Fabaceae, such as the genus Glycine, for example the genus and species Glycine max, which are high in
oleic acid. Since these organisms are only low in linoleic acid (Mikoklajczak et al., Journal of the American Oil Chemical
Society, 38, 1961, 678 - 681), the use of the Δ5-desaturases for producing the starting arachidonic acid, or eicosapen-
taenoic acid, or docosapentaenoic acid, or docosahexaenoic acid is advantageous.
[0092] The method according to the invention advantageously employs the abovementioned nucleic acid sequences
or their derivatives or homologs which code for polypeptides which retain the enzymatic activity of the proteins encoded
by nucleic acid sequences. These sequences, individually or in combination with the polynucleotides according to the
invention, are cloned into expression constructs and used for the introduction into, and expression in, organisms. Owing
to their construction, these expression constructs make possible an advantageous optimal synthesis of the polyunsat-
urated fatty acids produced in the method according to the invention.
[0093] In a preferred embodiment, the method furthermore comprises the step of obtaining a cell or an intact organism
which comprises the nucleic acid sequences used in the method, where the cell and/or the organism is transformed with
a polynucleotide according to the invention, a gene construct or a vector as described below, alone or in combination
with further nucleic acid sequences which code for proteins of the fatty acid or lipid metabolism. In a further preferred
embodiment, this method furthermore comprises the step of obtaining the oils, lipids or free fatty acids from the organism
or from the culture. The culture can, for example, take the form of a fermentation culture, for example in the case of the
cultivation of microorganisms, such as, for example, Mortierella, Thalassiosira, Mantoniella, Ostreococcus, Saccharo-
myces or Thraustochytrium, or a greenhouse- or field-grown culture of a plant. The cell or the organism thus produced
is advantageously a cell of an oil-producing organism, such as an oil crop, such as, for example, peanut, oilseed rape,
canola, linseed, hemp, soybean, safflower, sunflowers or borage.
[0094] In the case of plant cells, plant tissue or plant organs, "growing" is understood as meaning, for example, the
cultivation on or in a nutrient medium, or of the intact plant on or in a substrate, for example in a hydroponic culture,
potting compost or on arable land.
[0095] Suitable organisms or host cells for the method according to the invention are those which are capable of
synthesizing fatty acids, specifically unsaturated fatty acids, and/or which are suitable for the expression of recombinant
genes. Examples which may be mentioned are plants such as Arabidopsis, Asteraceae such as Calendula or crop plants
such as soybean, peanut, castor-oil plant, sunflower, maize, cotton, flax, oilseed rape, coconut, oil palm, safflower
(Carthamus tinctorius) or cacao bean, microorganisms, such as fungi, for example the genus Mortierella, Thraustochytri-
um, Saprolegnia, Phytophthora or Pythium, bacteria, such as the genus Escherichia or Shewanella, yeasts, such as the
genus Saccharomyces, cyanobacteria, ciliates, algae such as Mantoniella or Ostreococcus, or protozoans such as
dinoflagellates, such as Thalassiosira or Crypthecodinium. Preferred organisms are those which are naturally capable
of synthesizing substantial amounts of oil, such as fungi, such as Mortierella alpina, Pythium insidiosum, Phytophthora
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infestans, or plants such as soybean, oilseed rape, coconut, oil palm, safflower, flax, hemp, castor-oil plant, Calendula,
peanut, cacao bean or sunflower, or yeasts such as Saccharomyces cerevisiae, with soybean, flax, oilseed rape, saf-
flower, sunflower, Calendula, Mortierella or Saccharomyces cerevisiae being especially preferred. In principle, suitable
as host organisms are, in addition to the abovementioned transgenic organisms, also transgenic animals, advantageously
nonhuman animals, for example Caenorhabditis elegans. Further suitable host cells and organisms have already been
described extensively above.
[0096] Transgenic plants which comprise the polyunsaturated fatty acids synthesized in the method according to the
invention can advantageously be marketed directly without there being any need for the oils, lipids or fatty acids syn-
thesized to be isolated. Plants for the method according to the invention are listed as meaning intact plants and all plant
parts, plant organs or plant parts such as leaf, stem, seeds, root, tubers, anthers, fibers, root hairs, stalks, embryos,
calli, cotelydons, petioles, harvested material, plant tissue, reproductive tissue and cell cultures which are derived from
the transgenic plant and/or can be used for bringing about the transgenic plant. In this context, the seed comprises all
parts of the seed such as the seed coats, epidermal cells, seed cells, endosperm or embryonic tissue. However, the
compounds produced in the method according to the invention can also be isolated from the organisms, advantageously
plants, in the form of their oils, fats, lipids and/or free fatty acids. Polyunsaturated fatty acids produced by this method
can be obtained by harvesting the organisms, either from the crop in which they grow, or from the field. This can be
done via pressing or extraction of the plant parts, preferably of the plant seeds. In this context, the oils, fats, lipids and/or
free fatty acids can be obtained by pressing by what is known as cold-beating or cold-pressing without applying heat.
To allow for greater ease of disruption of the plant parts, specifically the seeds, they are previously comminuted, steamed
or roasted. The seeds which have been pretreated in this manner can subsequently be pressed or extracted with solvent
such as warm hexane. The solvent is subsequently removed. In the case of microorganisms, the latter are, after har-
vesting, for example extracted directly without further methoding steps or else, after disruption, extracted via various
methods with which the skilled worker is familiar. In this manner, more than 96% of the compounds produced in the
method can be isolated. Thereafter, the resulting products are methoded further, i.e. refined. In this method, for example
the plant mucilages and suspended matter are first removed. What is known as desliming can be effected enzymatically
or, for example, chemico-physically by addition of acid such as phosphoric acid. Thereafter, the free fatty acids are
removed by treatment with a base, for example sodium hydroxide solution. The resulting product is washed thoroughly
with water to remove the alkali remaining in the product and then dried. To remove the pigments remaining in the product,
the products are subjected to bleaching, for example using fuller’s earth or active charcoal. At the end, the product is
deodorized, for example using steam.
[0097] The PUFAs or LCPUFAs produced by this method are preferably C18-, C20- or C22-fatty acid molecules, ad-
vantageously C20- or C22-fatty acid molecules, with at least two double bonds in the fatty acid molecule, preferably three,
four, five or six double bonds. These C18-, C20- or C22-fatty acid molecules can be isolated from the organism in the
form of an oil, a lipid or a free fatty acid. Suitable organisms are, for example, those mentioned above. Preferred organisms
are transgenic plants.
[0098] Described are oils, lipids or fatty acids or fractions thereof which have been produced by the abovedescribed
method, especially preferably oil, lipid or a fatty acid composition comprising PUFAs and being derived from transgenic
plants.
As described above, these oils, lipids or fatty acids advantageously comprise 6 to 15% of palmitic acid, 1 to 6% of stearic
acid, 7-85% of oleic acid, 0.5 to 8% of vaccenic acid, 0.1 to 1% of arachic acid, 7 to 25% of saturated fatty acids, 8 to
85% of monounsaturated fatty acids and 60 to 85% of polyunsaturated fatty acids, in each case based on 100% and on
the total fatty acid content of the organisms. Advantageous polyunsaturated fatty acids which are present in the fatty
acid esters or fatty acid mixtures are preferably at least 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1% of arachidonic
acid, based on the total fatty acid content. Moreover, the fatty acid esters or fatty acid mixtures which have been produced
by the method of the invention advantageously comprise fatty acids selected from the group of the fatty acids erucic
acid (13-docosaenoic acid), sterculic acid (9,10-methyleneoctadec-9-enoic acid), malvalic acid (8,9-methyleneheptadec-
8-enoic acid), chaulmoogric acid (cyclopentenedodecanoic acid), furan fatty acid (9,12-epoxyoctadeca-9,11-dienoic
acid), vernolic acid (9,10-epoxyoctadec-12-enoic acid), tarinic acid (6-octadecynoic acid), 6-nonadecynoic acid, santalbic
acid (t11-octadecen-9-ynoic acid), 6,9-octadecenynoic acid, pyrulic acid (t10-heptadecen-8-ynoic acid), crepenynic acid
(9-octadecen-12-ynoic acid), 13,14-dihydrooropheic acid, octadecen-13-ene-9,11-diynoic acid, petroselenic acid (cis-
6-octadecenoic acid), 9c,12t-octadecadienoic acid, calendulic acid (8t10t12c-octadecatrienoic acid), catalpic acid
(9t11t13c-octadecatrienoic acid), eleostearic acid (9c11t13t-octadecatrienoic acid), jacaric acid (8c10t12c-octadeca-
trienoic acid), punicic acid (9c11 t13c-octadecatrienoic acid), parinaric acid (9c11t13t15c-octadecatetraenoic acid), pi-
nolenic acid (all-cis-5,9,12-octadecatrienoic acid), laballenic acid (5,6-octadecadienallenic acid), ricinoleic acid (12-hy-
droxyoleic acid) and/or coriolic acid (13-hydroxy-9c,11t-octadecadienoic acid). The abovementioned fatty acids are, as
a rule, advantageously only found in traces in the fatty acid esters or fatty acid mixtures produced by the method according
to the invention, that is to say that, based on the total fatty acids, they occur to less than 30%, preferably to less than
25%, 24%, 23%, 22% or 21%, especially preferably to less than 20%, 15%, 10%, 9%, 8%, 7%, 6% or 5%, very especially
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preferably to less than 4%, 3%, 2% or 1%. The fatty acid esters or fatty acid mixtures produced by the method according
to the invention advantageously comprise less than 0.1%, based on the total fatty acids, or no butyric acid, no cholesterol,
no clupanodonic acid (= docosapentaenoic acid, C22:5A4,8,12,11,21) and no nisinic acid (tetracosahexaenoic acid,
C23:6Δ3,8,12,15,18,21).
[0099] The oils, lipids or fatty acids preferably comprise at least 0.5%, 1%, 2%, 3%, 4% or 5%, advantageously at
least 6%, 7%, 8%, 9% or 10%, especially advantageously at least 11%, 12%, 13%, 14% or 15% of ARA or at least 0.5%,
1%, 2%, 3%, 4% or 5%, advantageously at least 6% or 7%, especially advantageously at least 8%, 9% or 10% of EPA
and/or DHA, based on the total fatty acid content of the production organism, advantageously of a plant, especially
advantageously of an oil crop plant such as soybean, oilseed rape, coconut, oil palm, safflower, flax, hemp, castor-oil
plant, Calendula, peanut, cacao bean, sunflower, or the abovementioned further mono- or dicotyledonous oil crop plants.
[0100] Furthermore described is the use of the oil, lipid, the fatty acids and/or the fatty acid composition in feedstuffs,
foodstuffs, cosmetics or pharmaceuticals. The oils, lipids, fatty acids or fatty acid mixtures can be used in the manner
with which the skilled worker is familiar for mixing with other oils, lipids, fatty acids or fatty acid mixtures of animal origin,
such as, for example, fish oils. These oils, lipids, fatty acids or fatty acid mixtures, which are composed of vegetable
and animal constituents, may also be used for the preparation of feedstuffs, foodstuffs, cosmetics or pharmaceuticals.
[0101] The term "oil", "lipid" or "fat" is understood as meaning a fatty acid mixture comprising unsaturated, saturated,
preferably esterified, fatty acid(s). The oil, lipid or fat is preferably high in polyunsaturated free or, advantageously,
esterified fatty acid(s), in particular linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, α-linolenic
acid, stearidonic acid, eicosatetraenoic acid, eicosapentaenoic acid, docosapentaenoic acid or docosahexaenoic acid.
The amount of unsaturated esterified fatty acids preferably amounts to approximately 30%, a content of 50% is more
preferred, a content of 60%, 70%, 80% or more is even more preferred. For the analysis, the fatty acid content can, for
example, be determined by gas chromatography after converting the fatty acids into the methyl esters by transesterifi-
cation. The oil, lipid or fat can comprise various other saturated or unsaturated fatty acids, for example calendulic acid,
palmitic acid, palmitoleic acid, stearic acid, oleic acid and the like. The content of the various fatty acids in the oil or fat
can vary, in particular depending on the starting organism.
[0102] The polyunsaturated fatty acids with advantageously at least two double bonds which are produced in the
method are, as described above, for example sphingolipids, phosphoglycerides, lipids, glycolipids, phospholipids, monoa-
cylglycerol, diacylglycerol, triacylglycerol or other fatty acid esters.
[0103] Starting from the polyunsaturated fatty acids with advantageously at least five or six double bonds, which acids
have been prepared in the method according to the invention, the polyunsaturated fatty acids which are present can be
liberated for example via treatment with alkali, for example aqueous KOH or NaOH, or acid hydrolysis, advantageously
in the presence of an alcohol such as methanol or ethanol, or via enzymatic cleavage, and isolated via, for example,
phase separation and subsequent acidification via, for example, H2SO4. The fatty acids can also be liberated directly
without the abovedescribed methoding step.
[0104] After their introduction into an organism, advantageously a plant cell or plant, the nucleic acids used in the
method can either be present on a separate plasmid or, advantageously, integrated into the genome of the host cell. In
the case of integration into the genome, integration can be random or else be effected by recombination such that the
native gene is replaced by the copy introduced, whereby the production of the desired compound by the cell is modulated,
or by the use of a gene in "trans", so that the gene is linked operably with a functional expression unit which comprises
at least one sequence which ensures the expression of a gene and at least one sequence which ensures the polyade-
nylation of a functionally transcribed gene. The nucleic acids are advantageously introduced into the organisms via
multiexpression cassettes or constructs for multiparallel expression, advantageously into the plants for the multiparallel
seed-specific expression of genes.
[0105] Mosses and algae are the only known plant systems which produce substantial amounts of polyunsaturated
fatty acids such as arachidonic acid (ARA) and/or eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA).
Mosses comprise PUFAs in membrane lipids, while algae, organisms which are related to algae and a few fungi also
accumulate substantial amounts of PUFAs in the triacylglycerol fraction. This is why nucleic acid molecules which are
isolated from such strains that also accumulate PUFAs in the triacylglycerol fraction are particularly advantageous for
the method according to the invention and thus for the modification of the lipid and PUFA production system in a host,
in particular plants such as oil crops, for example oilseed rape, canola, linseed, hemp, soybeans, sunflowers and borage.
They can therefore be used advantageously in the method according to the invention.
[0106] Substrates which are suitable for the polypeptides according to the invention of the fatty acid or lipid metabolism
selected from the group acyl-CoA dehydrogenase(s), acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioeste-
rase(s), fatty acid acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s), fatty acid
hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-coenzyme A oxidase(s), fatty acid desaturase(s), fatty acid
acetylenase(s), lipoxygenase(s), triacylglycerol lipase(s), allene oxide synthase(s), hydroperoxide lyase(s) or fatty acid
elongase(s) are advantageously C16-, C18- or C20-fatty acids. The fatty acids converted as substrates in the method are
preferably converted in the form of their acyl-CoA esters and/or their phospholipid esters.
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[0107] To produce the long-chain PUFAs according to the method of the invention, the polyunsaturated C18-fatty acids
must first be desaturated by the enzymatic activity of a desaturase and subsequently be elongated by at least two carbon
atoms via an elongase. After one elongation cycle, this enzyme activity gives C20-fatty acids and after two elongation
cycles, C22-fatty acids. The activity of the desaturases and elongases used in the method according to the invention
preferably leads to C18-, C20- and/or C22-fatty acids, advantageously with at least two double bonds in the fatty acid
molecule, preferably with three, four, five or six double bonds, especially preferably to give C20- and/or C22-fatty acids
with at least two double bonds in the fatty acid molecule, preferably with three, four, five or six double bonds, very
especially preferably with five or six double bonds in the molecule. After a first desaturation and the elongation have
taken place, further desaturation and elongation steps such as, for example, such a desaturation in the Δ5 and Δ4
positions may take place. Products of the method according to the invention which are especially preferred are dihomo-
y-linolenic acid, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid and/or docosahexaenoic acid. The
C20-fatty acids with at least two double bonds in the fatty acid can be desatured by the enzymatic activity according to
the invention in the form of the free fatty acid or in the form of the esters, such as phospholipids, glycolipids, sphingolipids,
phosphoglycerides, monoacylglycerol, diacylglycerol or triacylglycerol.
[0108] The preferred biosynthesis site of fatty acids, oils, lipids or fats in the plants which are advantageously used
is, for example, in general the seed or cell strata of the seed, so that seed-specific expression of the nucleic acids used
in the method is sensible. However, it is obvious that the biosynthesis of fatty acids, oils or lipids need not be limited to
the seed tissue, but can also take place in a tissue-specific manner in all the other parts of the plant - for example in
epidermal cells or in the tubers.
[0109] If microorganism such as yeasts, such as Saccharomyces or Schizosaccharomyces, fungi such as Mortierella,
Aspergillus, Phytophthora, Entomophthora, Mucor or Thraustochytrium, algae such as Isochrysis, Mantoniella, Ostreo-
coccus, Phaeodactylum or Crypthecodinium are used as organisms in the method according to the invention, these
organisms are advantageously grown in fermentation cultures.
[0110] Owing to the use of the nucleic acids according to the invention which code for a desaturase, the polyunsaturated
fatty acids produced in the method can be increased by at least 5%, preferably by at least 10%, especially preferably
by at least 20%, very especially preferably by at least 50% in comparison with the wild type of the organisms which do
not comprise the nucleic acids recombinantly.
[0111] In principle, the polyunsaturated fatty acids produced by the method according to the invention in the organisms
used in the method can be increased in two different ways. Advantageously, the pool of free polyunsaturated fatty acids
and/or the content of the esterified polyunsaturated fatty acids produced via the method can be enlarged. Advantageously,
the pool of esterified polyunsaturated fatty acids in the transgenic organisms is enlarged by the method according to the
invention.
[0112] If microorganisms are used as organisms in the method according to the invention, they are grown or cultured
in a manner with which the skilled worker is familiar, depending on the host organism. As a rule, microorganisms are
grown in a liquid medium comprising a carbon source, usually in the form of sugars, a nitrogen source, usually in the
form of organic nitrogen sources such as yeast extract or salts such as ammonium sulfate, trace elements such as salts
of iron, manganese and magnesium and, if appropriate, vitamins, at temperatures of between 0°C and 100°C, preferably
between 10°C and 60°C, while introducing oxygen gas. The pH of the nutrient liquid can either be kept constant, that is
to say regulated during the culturing period, or not. The cultures can be grown batchwise, semi-batchwise or continuously.
Nutrients can be provided at the beginning of the fermentation or fed in semicontinuously or continuously. The polyun-
saturated fatty acids produced can be isolated from the organisms as described above by methods known to the skilled
worker, for example by extraction, distillation, crystallization, if appropriate precipitation with salt, and/or chromatography.
To this end, the organisms can advantageously be disrupted beforehand.
[0113] If the host organisms are microorganisms, the methods according to the invention is advantageously carried
out at a temperature of between 0°C and 95°C, preferably between 10°C and 85°C, especially preferably between 15°C
and 75°C, very especially preferably between 15°C and 45°C.
[0114] In this method, the pH value is advantageously kept between pH 4 and 12, preferably between pH 6 and 9,
especially preferably between pH 7 and 8.
[0115] The method according to the invention can be operated batchwise, semibatchwise or continuously. An overview
over known cultivation methods can be found in the textbook by Chmiel (Bioprozeßtechnik 1. Einführung in die Biover-
fahrenstechnik [Biomethod technology 1. Introduction to biomethod technology] (Gustav Fischer Verlag, Stuttgart, 1991))
or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen [Bioreactors and peripheral equipment] (Vieweg
Verlag, Braunschweig/Wiesbaden, 1994)).
[0116] The culture medium to be used must suitably meet the requirements of the strains in question. Descriptions of
culture media for various microorganisms can be found in the textbook "Manual of Methods for General Bacteriology"
of the American Society for Bacteriology (Washington D.C., USA, 1981).
[0117] As described above, these media which can be employed in accordance with the invention usually comprise
one or more carbon sources, nitrogen sources, inorganic salts, vitamins and/or trace elements.
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[0118] Preferred carbon sources are sugars, such as mono-, di- or polysaccharides. Examples of very good carbon
sources are glucose, fructose, mannose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch
or cellulose. Sugars can also be added to the media via complex compounds such as molasses or other by-products
from sugar raffination. The addition of mixtures of a variety of carbon sources may also be advantageous. Other possible
carbon sources are oils and fats such as, for example, soya oil, sunflower oil, peanut oil and/or coconut fat, fatty acids
such as, for example, palmitic acid, stearic acid and/or linoleic acid, alcohols and/or polyalcohols such as, for example,
glycerol, methanol and/or ethanol, and/or organic acids such as, for example, acetic acid and/or lactic acid.
[0119] Nitrogen sources are usually organic or inorganic nitrogen compounds or materials comprising these com-
pounds. Examples of nitrogen sources comprise ammonia in liquid or gaseous form or ammonium salts such as am-
monium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates, urea,
amino acids or complex nitrogen sources such as cornsteep liquor, soya meal, soya protein, yeast extract, meat extract
and others. The nitrogen sources can be used individually or as a mixture.
[0120] Inorganic salt compounds which may be present in the media comprise the chloride, phosphorus and sulfate
salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron.
[0121] Inorganic sulfur-containing compounds such as, for example, sulfates, sulfites, dithionites, tetrathionates, thi-
osulfates, sulfides, or else organic sulfur compounds such as mercaptans and thiols may be used as sources of sulfur
for the production of sulfur-containing fine chemicals, in particular of methionine.
[0122] Phosphoric acid, potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding
sodium-containing salts may be used as sources of phosphorus.
[0123] Chelating agents may be added to the medium in order to keep the metal ions in solution. Particularly suitable
chelating agents comprise dihydroxyphenols such as catechol or protocatechuate and organic acids such as citric acid.
[0124] The fermentation media used according to the invention for cultivating microorganisms usually also comprise
other growth factors such as vitamins or growth promoters, which include, for example, biotin, riboflavin, thiamine, folic
acid, nicotinic acid, panthothenate and pyridoxine. Growth factors and salts are frequently derived from complex media
components such as yeast extract, molasses, cornsteep liquor and the like. It is moreover possible to add suitable
precursors to the culture medium. The exact composition of the media compounds depends heavily on the particular
experiment and is decided upon individually for each specific case. Information on the optimization of media can be
found in the textbook "Applied Microbiol. Physiology, A Practical Approach" (Editors P.M. Rhodes, P.F. Stanbury, IRL
Press (1997) pp. 53-73, ISBN 0 19 963577 3). Growth media can also be obtained from commercial suppliers, for
example Standard 1 (Merck) or BHI (brain heart infusion, DIFCO) and the like.
[0125] All media components are sterilized, either by heat (20 min at 1.5 bar and 121 °C) or by filter sterilization. The
components may be sterilized either together or, if required, separately. All media components may be present at the
start of the cultivation or added continuously or batchwise, as desired.
[0126] The culture temperature is normally between 15°C and 45°C, preferably at from 25°C to 40°C, and may be
kept constant or altered during the experiment. The pH of the medium should be in the range from 5 to 8.5, preferably
around 7.0. The pH for cultivation can be controlled during cultivation by adding basic compounds such as sodium
hydroxide, potassium hydroxide, ammonia and aqueous ammonia or acidic compounds such as phosphoric acid or
sulfuric acid. Foaming can be controlled by employing antifoams such as, for example, fatty acid polyglycol esters. To
maintain the stability of plasmids it is possible to add to the medium suitable substances having a selective effect, for
example antibiotics. Aerobic conditions are maintained by introducing oxygen or oxygen-containing gas mixtures such
as, for example, ambient air, into the culture. The temperature of the culture is normally 20°C to 45°C and preferably
25°C to 40°C. The culture is continued until formation of the desired product is at a maximum. This aim is normally
achieved within 10 hours to 160 hours.
[0127] The fermentation broths obtained in this way, in particular those containing polyunsaturated fatty acids, usually
contain a dry mass of from 7.5 to 25% by weight.
[0128] The fermentation broth can then be methoded further. The biomass may, according to requirement, be removed
completely or partially from the fermentation broth by separation methods such as, for example, centrifugation, filtration,
decanting or a combination of these methods or be left completely in said broth. It is advantageous to method the biomass
after its separation.
[0129] However, the fermentation broth can also be thickened or concentrated without separating the cells, using
known methods such as, for example, with the aid of a rotary evaporator, thin-film evaporator, falling-film evaporator,
by reverse osmosis or by nanofiltration. Finally, this concentrated fermentation broth can be methoded to obtain the fatty
acids present therein.
[0130] The polynucleotides or polypeptides of the present invention which are involved in the metabolism of lipids and
fatty acids, PUFA cofactors and enzymes or in the transport of lipophilic compounds across membranes are used in the
method according to the invention for the modulation of the production of PUFAs in transgenic organisms, advantageously
in plants, such as maize, wheat, rye, oats, triticale, rice, barley, soybean, peanut, cotton, Linum species such as linseed
or flax, Brassica species such as oilseed rape, canola and turnip rape, pepper, sunflower, borage, evening primrose
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and Tagetes, Solanaceae plants such as potato, tobacco, eggplant and tomato, Vicia species, pea, cassava, alfalfa,
bushy plants (coffee, cacao, tea), Salix species, trees (oil palm, coconut) and perennial grasses and fodder crops, either
directly (for example when the overexpression or optimization of a fatty acid biosynthesis protein has a direct effect on
the yield, production and/or production efficiency of the fatty acid from modified organisms) and/or can have an indirect
effect which nevertheless leads to an enhanced yield, production and/or production efficiency of the PUFAs or a reduction
of undesired compounds (for example when the modulation of the metabolism of lipids and fatty acids, cofactors and
enzymes leads to modifications of the yield, production and/or production efficiency or the composition of the desired
compounds within the cells, which, in turn, can affect the production of one or more fatty acids).
[0131] The combination of various precursor molecules and biosynthesis enzymes leads to the production of various
fatty acid molecules, which has a decisive effect on lipid composition, since polyunsaturated fatty acids (= PUFAs) are
not only incorporated into triacylglycerol but also into membrane lipids.
[0132] Brassicaceae, Boraginaceae, Primulaceae, or Linaceae are particularly suitable for the production of PUFAs,
for example stearidonic acid, eicosapentaenoic acid and docosahexaenoic acid. Linseed (Linum usitatissimum) is es-
pecially advantageously suitable for the production of PUFAs with the nucleic acid sequences according to the invention,
advantageously, as described, in combination with further desaturases and elongases.
[0133] Lipid synthesis can be divided into two sections: the synthesis of fatty acids and their binding to sn-glycerol-3-
phosphate, and the addition or modification of a polar head group. Usual lipids which are used in membranes comprise
phospholipids, glycolipids, sphingolipids and phosphoglycerides. Fatty acid synthesis starts with the conversion of acetyl-
CoA into malonyl-CoA by acetyl-CoA carboxylase or into acetyl-ACP by acetyl transacylase. After a condensation
reaction, these two product molecules together form acetoacetyl-ACP, which is converted via a series of condensation,
reduction and dehydratation reactions so that a saturated fatty acid molecule with the desired chain length is obtained.
The production of the unsaturated fatty acids from these molecules is catalyzed by specific desaturases, either aerobically
by means of molecular oxygen or anaerobically (regarding the fatty acid synthesis in microorganisms, see F.C. Neidhardt
et al. (1996) E. coli and Salmonella. ASM Press: Washington, D.C., pp. 612-636 and references cited therein; Lengeler
et al. (Ed.) (1999) Biology of Procaryotes. Thieme: Stuttgart, New York, and the references therein, and Magnuson, K.,
et al. (1993) Microbiological Reviews 57:522-542 and the references therein). To undergo the further elongation steps,
the resulting phospholipid-bound fatty acids must be returned to the fatty acid CoA ester pool from the phospholipids.
This is made possible by acyl-CoA:lysophospholipid acyltransferases. Moreover, these enzymes are capable of trans-
ferring the elongated fatty acids from the CoA esters back to the phospholipids. If appropriate, this reaction sequence
can be traversed repeatedly.
[0134] Examples of precursors for the biosynthesis of PUFAs are oleic acid, linoleic acid and linolenic acid. These
C18-carbon fatty acids must be elongated to C20 and C22 in order to obtain fatty acids of the eicosa and docosa chain
type. With the aid of the desaturases used in the method, such as the Δ12-, Δ15-, Δ12- and Δ15-, ω3-, Δ4-, Δ5-and Δ6-
desaturases and/or the Δ5-, Δ6-elongases, arachidonic acid, eicosapentaenoic acid, docosapentaenoic acid or docosa-
hexaenoic acid, advantageously eicosapentaenoic acid and/or docosahexaenoic acid, can be produced and subse-
quently employed in various applications regarding foodstuffs, feedstuffs, cosmetics or pharmaceuticals. C20- and/or
C22-fatty acids with at least two, advantageously at least three, four, five or six, double bonds in the fatty acid molecule,
preferably C20- or C22-fatty acids with advantageously four, five or six double bonds in the fatty acid molecule, can be
prepared using the abovementioned enzymes. Desaturation may take place before or after elongation of the fatty acid
in question. This is why the products of the desaturase activities and of the further desaturation and elongation steps
which are possible result in preferred PUFAs with a higher degree of desaturation, including a further elongation from
C20- to C22-fatty acids, to fatty acids such as γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, stearidonic acid,
eicosatetraenoic acid or eicosapentaenoic acid. Substrates of the desaturases and elongases used in the method
according to the invention are C16-, C18- or C20-fatty acids such as, for example, linoleic acid, γ-linolenic acid, α-linolenic
acid, dihomo-γ-linolenic acid, eicosatetraenoic acid or stearidonic acid. Preferred substrates are linoleic acid, γ-linolenic
acid and/or α-linolenic acid, dihomo-γ-linolenic acid or arachidonic acid, eicosatetraenoic acid or eicosapentaenoic acid.
The synthesized C20-or C22-fatty acids with at least two, three, four, five or six double bonds in the fatty acid are obtained
in the method according to the invention in the form of the free fatty acid or in the form of their esters, for example in the
form of their glycerides.
[0135] The term "glyceride" is understood as meaning a glycerol esterified with one, two or three carboxyl radicals
(mono-, di- or triglyceride). "Glyceride" is also understood as meaning a mixture of various glycerides. The glyceride or
glyceride mixture may comprise further additions, for example free fatty acids, antioxidants, proteins, carbohydrates,
vitamins and/or other substances.
[0136] For the purposes of the method according to invention, a "glyceride" is furthermore understood as meaning
glycerol derivatives. In addition to the abovedescribed fatty acid glycerides, these also include glycerophospholipids and
glyceroglycolipids. Preferred examples which may be mentioned in this context are the glycerophospholipids such as
lecithin (phosphatidylcholine), cardiolipin, phosphatidylglycerol, phosphatidylserine and alkylacylglycerophospholipids.
[0137] Furthermore, fatty acids must subsequently be translocated to various modification sites and incorporated into
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the triacylglycerol storage lipid. A further important step in lipid synthesis is the transfer of fatty acids to the polar head
groups, for example by glycerol fatty acid acyltransferase (see Frentzen, 1998, Lipid, 100(4-5):161-166).
[0138] Publications on plant fatty acid biosynthesis and on the desaturation, the lipid metabolism and the membrane
transport of lipidic compounds, on beta-oxidation, fatty acid modification and cofactors, triacylglycerol storage and tria-
cylglycerol assembly, including the references therein, see the following papers: Kinney, 1997, Genetic Engineering,
Ed.: JK Setlow, 19:149-166; Ohlrogge and Browse, 1995, Plant Cell 7:957-970; Shanklin and Cahoon, 1998, Annu. Rev.
Plant Physiol. Plant Mol. Biol. 49:611-641; Voelker, 1996, Genetic Engineering, Ed.: JK Setlow, 18:111-13; Gerhardt,
1992, Prog. Lipid R. 31:397-417; Gühnemann-Schäfer & Kindl, 1995, Biochim. Biophys Acta 1256:181-186; Kunau et
al., 1995, Prog. Lipid Res. 34:267-342; Stymne et al., 1993, in: Biochemistry and Molecular Biology of Membrane and
Storage Lipids of Plants, Ed.: Murata and Somerville, Rockville, American Society of Plant Physiologists, 150-158,
Murphy & Ross 1998, Plant Journal. 13(1):1-16.
[0139] The PUFAs produced in the method comprise a group of molecules which higher animals are no longer capable
of synthesizing and must therefore take up, or which higher animals are no longer capable of synthesizing themselves
in sufficient quantities and must therefore take up additional quantities, although they can be synthesized readily by
other organisms such as bacteria; for example, cats are no longer capable of synthesizing arachidonic acid.
[0140] Phospholipids for the purposes of the invention are understood as meaning phosphatidylcholine, phosphati-
dylethanolamine, phosphatidylserine, phosphatidylglycerol and/or phosphatidylinositol, advantageously phosphatidyl-
choline. The terms "production or productivity" are known in the art and encompasses the concentration of the fermentation
product (compounds of the formula I) which is formed within a specific period of time and in a specific fermentation
volume (for example kg of product per hour per liter). It also comprises the productivity within a plant cell or a plant, that
is to say the content of the desired fatty acids produced in the method relative to the content of all fatty acids in this cell
or plant. The term "production efficiency" comprises the time required for obtaining a specific production quantity (for
example the time required by the cell to establish a certain throughput rate of a fine chemical). The term "yield or
product/carbon yield" is known in the art and comprises the efficiency of the conversion of the carbon source into the
product (i.e. the fine chemical). This is usually expressed for example as kg of product per kg of carbon source. By
increasing the yield or production of the compound, the amount of the molecules obtained of this compound, or of the
suitable molecules of this compound obtained, in a specific culture quantity over a specified period of time is increased.
The terms "biosynthesis or biosynthetic pathway" are known in the art and comprise the synthesis of a compound,
preferably an organic compound, by a cell from intermediates, for example in a multi-step and strongly regulated method.
The terms "catabolism or catabolic pathway" are known in the art and comprise the cleavage of a compound, preferably
of an organic compound, by a cell to give catabolites (in more general terms, smaller or less complex molecules), for
example in a multi-step and strongly regulated method. The term "metabolism" is known in the art and comprises the
totality of the biochemical reactions which take place in an organism. The metabolism of a certain compound (for example
the metabolism of a fatty acid) thus comprises the totality of the biosynthetic pathways, modification pathways and
catabolic pathways of this compound in the cell which relate to this compound.
[0141] By employing, in the method according to the invention, the polynucleotides according to the invention and
optionally further polynucleotides which code for enzymes of the lipid or fatty acid metabolism it is possible to achieve
various advantageous effects. Thus, it is possible to influence the yield, production and/or production efficiency of the
polyunsaturated fatty acids in a plant, preferably in an oil crop plant, or in a microorganism. The number or activity of
the polypeptides or polynucleotides according to the invention can be increased, so that larger amounts of the gene
products and, ultimately, larger amounts of the compounds of the general formula I are produced. A de novo synthesis
in an organism, which, before the gene(s) in question was/were introduced, had been lacking the activity and ability to
biosynthesize the compounds, is also possible. The same applies analogously to the combination with further desaturases
or elongases or further enzymes of the fatty acid and lipid metabolism. The use of a variety of divergent sequences, i.e.
sequences which differ at the DNA sequence level, may also be advantageous in this context, or else the use of gene
expression promoters which makes possible a different gene expression as far as timing is concerned, for example as
a function of the degree of maturity of a seed or oil-storing tissue.
[0142] By introducing, into an organism, a polynucleotide according to the invention alone or in combination with other
genes into a cell it is possible not only to increase the biosynthetic flow towards the end product, but also to increase,
or to create de novo, the corresponding triacylglycerol composition. Equally, the number or activity of other genes which
are required for the import of nutrients for the biosynthesis of one or more fatty acids, oils, polar and/or neutral lipids can
be increased, so that the concentration of these precursors, cofactors or intermediates within the cells or within the
storage compartment is increased, whereby the ability of the cells to produce PUFAs is further enhanced. By optimizing
the activity, or increasing the number, of one or more polynucleotides or polypeptides according to the invention which
are involved in the biosynthesis of these compounds, or by destroying the activity of one or more genes which are
involved in the degradation of these compounds, it may be possible to increase the yield, production and/or production
efficiency of fatty acid and lipid molecules from organisms, in particular from plants. The fatty acids obtained in the
method are suitable as starting materials for the chemical synthesis of further products of interest. For example, they
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can be used for the preparation of pharmaceuticals, foodstuffs, animal feeds or cosmetics, either alone or in combination
with one another.
[0143] It can be seen from what has been said above that the invention also relates to a method for the preparation
of an oil, lipid or fatty acid composition, comprising the steps of the method according to the invention and the further
step of formulating the substance as an oil, lipid or fatty acid composition.
[0144] In a preferred embodiment of this method, the oil, lipid or fatty acid composition is formulated further to give a
drug, a cosmetic product, a foodstuff, a feedstuff, preferably fish food, or a food supplement.
[0145] Finally, the invention relates to the principle of using the polynucleotide, the vector, the host cell, the polypeptide
or the transgenic, nonhuman organism of the present invention for the production of an oil, lipid or fatty acid composition.
The latter is then preferably to be employed as drug, cosmetic product, foodstuff, feedstuff, preferably fish food, or food
supplement.
Figures
[0146]
Figure 1: Sequence alignment of the O. tauri Δ6-desaturase (SEQ ID No. 4) with the sequence from Emiliana huxleyi
(SEQ ID No. 2).
Figure 2: Gas-chromatographic analysis of the feeding of yeasts transformed with pYES2.1/V5-His-TOPO (A) and
pYES-SEQ1(Eh) (B). The substance fed was the fatty acid 20:3Δ8,11,14 (C). The Δ5-activity is demonstrated by
the appearance of an additional peak with the identity 20:4Δ5,8,11,14 (D).
Figure 3: Plasmid map of the binary construct LJB1589, transformed into Brassica napus, for the EPA synthesis in
seeds.
Figure 4: Synthetic pathways for PUFAs.
Examples
Example 1: General cloning methods
[0147] The cloning methods such as, for example, restriction cleavages, agarose gel electrophoresis, purification of
DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linkage of DNA fragments, transfor-
mation of Escherichia coli cells, bacterial cultures and the sequence analysis of recombinant DNA were carried out as
described by Sambrook et al. (1989) (Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6).
Example 2: Sequence analysis of recombinant DNA
[0148] Recombinant DNA molecules were sequenced with an ABI laser fluorescence DNA sequencer by the method
of Sanger (Sanger et al. (1977) Proc. Natl. Acad. Sci. USA74, 5463-5467). Fragments obtained by polymerase chain
reaction were sequenced and verified to avoid polymerase errors in constructs to be expressed.
Example 3: Lipid extraction from yeasts and plants
[0149] The effect of the genetic modification in plants, fungi, algae, ciliates or on the production of a desired compound
(such as a fatty acid) can be determined by growing the modified microorganisms or the modified plant under suitable
conditions (such as those described above) and analyzing the medium and/or the cellular components for the elevated
production of the desired product (i.e. of lipids or a fatty acid). These analytical techniques are known to the skilled
worker and comprise spectroscopy, thin-layer chromatography, various types of staining methods, enzymatic and micro-
biological methods and analytical chromatography such as high-performance liquid chromatography (see, for example,
Ullman, Encyclopedia of Industrial Chemistry, Vol. A2, p. 89-90 and p. 443-613, VCH: Weinheim (1985); Fallon, A., et
al., (1987) "Applications of HPLC in Biochemistry" in: Laboratory Techniques in Biochemistry and Molecular Biology,
Vol. 17; Rehm et al. (1993) Biotechnology, Vol. 3, Chapter III: "Product recovery and purification", p. 469-714, VCH:
Weinheim; Belter, P.A., et al. (1988) Bioseparations: downstream methoding for Biotechnology, John Wiley and Sons;
Kennedy, J.F., and Cabral, J.M.S. (1992) Recovery methods for biological Materials, John Wiley and Sons; Shaeiwitz,
J.A., and Henry, J.D. (1988) Biochemical Separations, in: Ullmann’s Encyclopedia of Industrial Chemistry, Vol. B3;
Chapter 11, p. 1-27, VCH: Weinheim; and Dechow, F.J. (1989) Separation and purification techniques in biotechnology,
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Noyes Publications).
[0150] In addition to the abovementioned methods, plant lipids are extracted from plant material as described by
Cahoon et al. (1999) Proc. Natl. Acad. Sci. USA 96 (22):12935-12940 and Browse et al. (1986) Analytic Biochemistry
152:141-145. The qualitative and quantitative analysis of lipids or fatty acids is described in Christie, William W., Advances
in Lipid Methodology, Ayr/Scotland: Oily Press (Oily Press Lipid Library; 2); Christie, William W., Gas Chromatography
and Lipids. A Practical Guide - Ayr, Scotland: Oily Press, 1989, Repr. 1992, IX, 307 pp. (Oily Press Lipid Library; 1);
"Progress in Lipid Research", Oxford: Pergamon Press, 1 (1952) - 16 (1977) under the title: Progress in the Chemistry
of Fats and Other Lipids CODEN.
[0151] In addition to measuring the end product of the fermentation, it is also possible to analyze other components
of the metabolic pathways which are used for the production of the desired compound, such as intermediates and by-
products, in order to determine the overall production efficiency of the compound. The analytical methods comprise
measuring the amount of nutrients in the medium (for example sugars, hydrocarbons, nitrogen sources, phosphate and
other ions), measuring the biomass composition and the growth, analyzing the production of conventional metabolites
of biosynthetic pathways and measuring gases which are generated during the fermentation. Standard methods for
these measurements are described in Applied Microbial Physiology; A Practical Approach, P.M. Rhodes and P.F. Stan-
bury, Ed., IRL Press, p. 103-129; 131-163 and 165-192 (ISBN: 0199635773) and references cited therein.
[0152] One example is the analysis of fatty acids (abbreviations: FAME, fatty acid methyl ester; GC-MS, gas liquid
chromatography/mass spectrometry; TAG, triacylglycerol; TLC, thin-layer chromatography).
[0153] Unambiguous proof for the presence of fatty acid products can be obtained by analyzing recombinant organisms
using standard analytical methods: GC, GC-MS or TLC, as described on several occasions by Christie and the references
therein (1997, in: Advances on Lipid Methodology, Fourth Edition: Christie, Oily Press, Dundee, 119-169; 1998, Gas-
chromatographie-Massenspektrometrie-Verfahren [Gas chromatography/mass spectrometry methods], Lipide
33:343-353).
[0154] The material to be analyzed can be disrupted by sonication, grinding in a glass mill, liquid nitrogen and grinding
or via other applicable methods. After disruption, the material must be centrifuged. The sediment is resuspended in
distilled water, heated for 10 minutes at 100°C, cooled on ice and recentrifuged, followed by extraction for one hour at
90°C in 0.5 M sulfuric acid in methanol with 2% dimethoxypropane, which leads to hydrolyzed oil and lipid compounds,
which give transmethylated lipids. These fatty acid methyl esters are extracted in petroleum ether and finally subjected
to a GC analysis using a capillary column (Chrompack, WCOT Fused Silica, CP-Wax-52 CB, 25 microM, 0.32 mm) at
a temperature gradient of between 170°C and 240°C for 20 minutes and 5 minutes at 240°C. The identity of the resulting
fatty acid methyl esters must be defined using standards which are available from commercial sources (i.e. Sigma).
Example 4: Cloning a desaturase gene from the alga Emiliana huxleyi
[0155] A sequence database of Emiliana huxleyi was searched using the known sequence of the Ostreococcus tauri
Δ6-desaturase (Domergue et al. (2005) Biochem J. 389(Pt 2):483-90, SEQ ID No. 3). It was possible to identify a
sequence with homology to the amino acid sequence of the Ostreococcus tauri Δ6-desaturase (SEQ ID No. 4). The
sequence was elongated in the 5’ and 3’ direction by means of RACE-PCR (Clontech, USA) following the manufacturer’s
instructions (SEQ ID No. 1), and the coding amino acid sequence (SEQ ID No. 2) checked with the amino acid sequence
of the Ostreococcus tauri Δ6-desaturase (SEQ ID No. 4) in a sequence alignment (Fig. 1). According to ClustalW, the
sequence alignment gives a sequence identity of 41 %. Other amino acid sequences such as, for example, the Mortierella
alpina d5-desaturase (WO2000/012720) show 22% identity.
[0156] To characterize the functions of SEQ ID No. 1 and of the corresponding amino acid sequence, the open reading
frame of the DNA was cloned downstream of the galactose-inducible GAL1 promoter of pYES2.1/V5-His-TOPO (Invit-
rogen), giving rise to the plasmid pYES-SEQ1(Eh). This plasmid was then transformed into the yeast strain INVSC-1
(Invitrogen) following the manufacturer’s instructions and selected on plates with DOB-U agar on the basis of uracil
auxotrophism. Positive colonies were identified by PCR. To this end, in each case 1 ml of defrosted cells, 200 mM dNTPs,
2.5 U Taq polymerase and 100 pmol of each primer were used to carry out in a total volume of 50 ml. The PCR conditions
are as follows: first denaturation at 95°C for 5 minutes, followed by 30 cycles of 30 seconds at 94°C, 1 minute at 55°C
and 2 minutes at 72°C, and a last elongation step for 10 minutes at 72°C. In parallel, the empty vector pYES2.1/V5-His-
TOPO was transformed in the abovedescribed manner into competent yeast cells of the strain INVSC-1. Yeast cells
with the plasmids pYES-SEQ1(Eh) were incubated for 12 h in liquid DOB-U medium at 28°C, 200 rpm, and then for a
further 12 h in induction medium (DOB-U+2% (w/v) galactose + 2% (w/v) raffinose) and 250 mM of fatty acids added to
the medium. The specificity and activity of the gene to be characterized can be determined with reference to the added
fatty acids.
[0157] Yeasts which have been transformed with the plasmids pYES2/V5-His-TOPO or pYES-SEQ1 (Eh) were ana-
lyzed as follows:
[0158] The yeast cells from the main cultures were harvested by centrifugation (100 x g, 5 min, 20°C) and washed
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with 100 mM NaHCO3, pH 8.0 to remove residual medium and fatty acids. Starting with the yeast cell sediments, fatty
acid methyl esters (FAMEs) were prepared by acid methanolysis. To this end, the cell sediments were incubated for
one hour at 80°C together with 2 ml of 1 N methanolic sulfuric acid and 2% (v/v) of dimethoxypropane. The FAMEs were
extracted twice with petroleum ether (PE). To remove nonderivatized fatty acids, the organic phases were washed in
each case once with 2 ml of 100 mM NaHCO3 pH 8.0 and 2 ml of distilled water. Thereafter, the PE phases were dried
with Na2SO4, evaporated under argon and taken up in 100 ml of PE. The samples were separated on a DB-23 capillary
column (30 m, 0.25 mm, 0.25 mm, Agilent) in a Hewlett-Packard 6850 gas chromatograph equipped with flame ionization
detector. The conditions for the GLC analysis were as follows: the oven temperature was programmed from 50°C to
250°C with an increment of 5°C/min and finally 10 min at 250°C (holding).
[0159] The signals are identified by comparing the retention times with corresponding fatty acid standards (Sigma).
The methodology is described for example in Napier and Michaelson, 2001, Lipids. 36(8):761-766; Sayanova et al.,
2001, Journal of Experimental Botany. 52(360):1581-1585, Sperling et al., 2001, Arch. Biochem. Biophys. 388(2):293-298
and Michaelson et al., 1998, FEBS Letters. 439(3):215-218.
Activity and substrate determination of the desaturases identified
[0160] The substrate specificity of SEQ ID No. 1 was determined after expression and feeding of various fatty acids.
Surprisingly, only 20:3Δ8,11,14 and 20:4Δ8,11,14,17 of the fed substrates were converted. Thus, the coding sequence
SEQ ID No. 1 has Δ5-desaturase activity and is hereinbelow referred to as d5Des(Eh). The specific conversion of the
fatty acids fed is shown in fig. 2. After 48 h, 65-70% of the fed fatty acid is converted into the product, the conversion
rate being calculated using the following formula: 
[0161] The percentage of the converted fatty acid in the total fatty acids is 7-8%. The converted fatty acid is distributed
to in each case 9% to the lipids phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine. The lipid phos-
phatidylcholin only accounts for 2%. The remaining fatty acids are found in the neutral lipids. The fact that only little of
the product of the d5Des(Eh) is accumulated in phosphatidylcholine, in combination with the distribution to a multiplicity
of further lipid classes, shows the coenzyme A specificity of d5Des(Eh).
Example 7: Production of transgenic plants for the production of long-chain polyunsaturated fatty acids
[0162] To produce long-chain polyunsaturated fatty acids in plants, various genes of the metabolic pathway are com-
bined on a binary vector. To produce the fatty acid arachidonic acid (20:4Δ5,8,11,14), genes as described in table 1
were combined. Analogously, genes as described in Table 2 were combined for the production of the fatty acid eicos-
apentaenoic acid (20:5Δ5,8,11,14,17). Analogously, the genes as described in Table 3 were combined for producing
the fatty acid docosahexaenoic acid (22:6Δ4,7,10,13,16,19).
Table 1: Gene combination for the production of arachidonic acid
Genes Activity SEQ ID No.
D6Des(Pir) Δ6-desaturase 5
D6Elo(Pp) Δ6-elongase 7
D5Des(Eh) Δ5-desaturase 1
D12Des(Ps) Δ12-desaturase 9
Table 2: Gene combination for the production of eicosapentaenoic acid
Genes Activity SEQ ID No.
D6Des(Pir) Δ6-desaturase 5
D6EIo(Pp) Δ6-elongase 7
D5Des(Eh) Δ5-desaturase 1
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[0163] Further transformation vectors based on pSUN-USP were generated for the transformation of plants. To this
end, Notl cleavage sites were introduced at the 5’ and at the 3’ end of the coding sequence, using the following primer
pairs (see Table 7).
Composition of the PCR mix (50 ml):
[0164]
5.00 ml template cDNA
5.00 ml 10x buffer (Advantage polymerase) + 25mM MgCl2
5.00 ml 2mM dNTP
1.25 ml of each primer (10 pmol/mL)
0.50 ml Advantage polymerase
[0165] The Advantage polymerase from Clontech is employed.
PCR reaction conditions:
[0166]
Annealing temperature: 1 min 55°C
Denaturation temperature: 1 min 94°C
Elongation temperature: 2 min 72°C
Number of cycles: 35
(continued)
Genes Activity SEQ ID No.
ω3-Des(Pi) omega 3-desaturase 11
D12Des(Ps) Δ12-desaturase 9
D15Des(Perf) Δ15-desaturase 13
Table 3: Gene combination for the production of docosahexaenoic acid
Genes Activity SEQ ID No.
D6Des(Pir) Δ6-desaturase 5
D6Elo(Pp) Δ6-elongase 7
D5Des(Eh) Δ5-desaturase 1
ω3-Des(Pi) omega 3-desaturase 11
D12Des(Ps) Δ12-desaturase 9
D15Des(Perf) Δ15-desaturase 13
D5Elo(Ot) Δ5-elongase 15
D4Des(Tc) Δ4-desaturase 17
Table 7: Primer sequences (for cloning transformation vectors based on pSUN-USP)
Gene Primer SEQ ID No.
D6-Des(Pir) Fwd: gcggccgcgccatggtggacctcaagcctgg 18
Rvs: gcggccgttacatcgctgggaactcgg 19
D5-Des(Eh) Fwd: gcggccgcgccatgtcattggctgctaaagatg 20
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[0167] The PCR products were incubated with the restriction enzyme Notl for 4 h at 37°C. The plant expression vector
pSUN300-USP is incubated in the same manner. Thereafter, the PCR products and the 7624 bp vector are separated
by agarose gel electrophoresis, and the corresponding DNA fragments are excised. The DNA is purified by means of
the Qiagen gel purification kit, following the manufacturer’s instructions. Thereafter, vector and PCR products are ligated.
The Rapid Ligation kit from Roche is used for this purpose. The plasmids generated are verified by sequencing.
[0168] pSUN300 is a derivative of the plasmid pPZP (Hajdukiewicz, P, Svab, Z, Maliga, P., (1994) The small versatile
pPZP family of Agrobacterium binary vectors for plant transformation. Plant Mol Biol 25:989-994). pSUN-USP originated
from pSUN300, by inserting a USP promoter into pSUN300 in the form of an EcoRI fragment. The polyadenylation signal
is the OCS gene from the A. tumefaciens Ti plasmid (ocs-Terminator, Genbank Accession V00088) (De Greve, H.,
Dhaese, P., Seurinck, J., Lemmers, M., Van Montagu, M. and Schell, J. Nucleotide sequence and transcript map of the
Agrobacterium tumefaciens Ti plasmid-encoded octopine synthase gene J. Mol. Appl. Genet. 1 (6), 499-511 (1982).
The USP promoter corresponds to nucleotides 1 to 684 (Genbank Accession X56240), where part of the noncoding
region of the USP gene is present in the promoter. The promoter fragment which is 684 base pairs in size was amplified
by a PCR reaction using standard methods with the aid of a synthesized primer and by means of a commercially available
T7 standard primer (Stratagene).
(Primer sequence:
[0169] The PCR fragment was recut with EcoRI/SalI and inserted into the vector pSUN300 with OCS terminator. This
gave rise to the plasmid named pSUN-USP, which can be employed for transforming plants by means of Agrobacterium
tumefaciens.
a) Generation of transgenic oilseed rape plants (modified method of Moloney et al., 1992, Plant Cell Reports, 8:238-242)
[0170] To generate transgenic oilseed rape plants, binary vectors such as the pSUN plasmids described hereinabove
or, by way of example, the derivative LJB1589 (SEQ ID No. 34, plasmid map in fig. 3) with the relevant gene combinations
were transformed into Agrobacterium tumefaciens C58C1:SHA001 (Deblaere et al, 1984, Nucl. Acids. Res. 13,
4777-4788). A 1:50 dilution of an overnight culture of a positively transformed agrobacterial colony in Murashige-Skoog
medium (Murashige and Skoog 1962 Physiol. Plant. 15, 473) supplemented with 3% sucrose (3MS medium) was used
for transforming oilseed rape plants (cv. Kumily, Swalöf Weibul, Sweden). Petioles or hypocotyls of freshly germinated
sterile oilseed rape plants (in each case approx. 1 cm2) were incubated with a 1:50 agrobacterial dilution for 5-10 minutes
in a Petri dish. This was followed by 3 days of coincubation in the dark at 25°C on 3MS medium supplemented with
0.8% Bacto agar. After 3 days, the cultivation was continued with 16 hours light/8 hours dark and was continued, in a
(continued)
Gene Primer SEQ ID No.
Rvs: gcggccgtcaatgacctgtaactctaac 21
O3-Des(Pi) Fwd: gcggccgcgccatggcgacgaaggaggcgta 22
Rvs: gcggccgcgttacgtggacttggtcttggcc 23
D6-Elo(Pp) Fwd: gcggccgcgccatggaggtcgtggagagattc 24
Rvs: gcggccgcgtcactcagttttagctccc 25
D12Des(Ps) Fwd: gcggccgccatggcgatcctgaacccggag 26
Rvs: gcggccgcttagagcttgttcttgtagaag 27
D15Des(Perf) Fwd: gcggccgccatggccgtttcttccggtgc 28
Rvs: gcggccgcctaaatctttttggaaggaaag 29
D5Elo(Ot) Fwd: gcggccgcgccatgagcgcctccggtgcgctg 30
Rvs: gcggccgcgttagtcaatttttc 31
D4Des(Tc) Fwd: gcggccgcgccatgacggtcggctacgacgag 32
Rvs: gcggccgcgtcaggcagcgcgctgccagg 33
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1-week rhythm, on MS medium supplemented with 500 mg/l Claforan (cefotaxim-sodium), 50 mg/l Kanamycin, 20 microM
benzylaminopurine (BAP) and 1.6 g/l glucose. Growing shoots were transferred to MS medium supplemented with 2%
sucrose, 250 mg/l Claforan and 0.8% Bacto agar. If no roots had formed after three weeks, the growth hormone 2-
indolebutyric acid was added to the medium to promote rooting.
[0171] Regenerated shoots were obtained on 2MS medium supplemented with kanamycin and Claforan, transferred
into soil once rooted, and after cultivation for two weeks grown in a controlled-environment cabinet or in a greenhouse,
flowering was induced, mature seeds were harvested and analyzed for expression of the desaturase or elongase genes
by means of lipid analyses as described by way of example in Qiu et al. 2001, J. Biol. Chem. 276, 31561-31566.
b) Generation of transgenic linseed plants
[0172] Transgenic linseed plants can be generated for example by the method of Bell et al., 1999, In Vitro Cell. Dev.
Biol.-Plant. 35(6):456-465 by means of particle bombardment. Agrobacterial-mediated transformations can be effected
for example as described by Mlynarova et al. (1994), Plant Cell Report 13: 282-285.
SEQUENCE LISTING
[0173]
<110> BASF PLANT SCIENCE GMBH
<120> Deasaturase and method for the production of polyunsaturated fatty acids
in transgenic organisms
<130> BPS65606PC
<160> 35
<170> PatentIn version 3.5
<210> 1
<211> 1368
<212> DNA
<213> Emiliana huxleyi
<400> 1
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<210> 2
<211> 455
<212> PRT
<213> Emiliana huxleyi
<400> 2
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<210> 3
<211> 1371
<212> DNA
<213> Ostreococcus tauri
<400> 3
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<210> 4
<211> 456
<212> PRT
<213> Ostreococcus tauri
<400> 4
EP 2 281 051 B1
39
5
10
15
20
25
30
35
40
45
50
55
EP 2 281 051 B1
40
5
10
15
20
25
30
35
40
45
50
55
EP 2 281 051 B1
41
5
10
15
20
25
30
35
40
45
50
55
<210> 5
<211> 1380
<212> DNA
<213> Pythium irregulare
<400> 5
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<210> 6
<211> 459
<212> PRT
<213> Pythium irregulare
<400> 6
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<210> 7
<211> 873
<212> DNA
<213> Physcomitrella patens
<400> 7
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<210> 8
<211> 290
<212> PRT
<213> Physcomitrella patens
<400> 8
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<210> 9
<211> 1197
<212> DNA
<213> Phytophtora sojae
<400> 9
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<210> 10
<211> 398
<212> PRT
<213> Phytophtora sojae
<400> 10
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<210> 11
<211> 1086
<212> DNA
<213> Phytophtora infestans
<400> 11
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<210> 12
<211> 361
<212> PRT
<213> Phytophtora infestans
<400> 12
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<210> 13
<211> 1176
<212> DNA
<213> Perilla fruticosa
<400> 13
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<210> 14
<211> 391
<212> PRT
<213> Perilla fruticosa
<400> 14
EP 2 281 051 B1
55
5
10
15
20
25
30
35
40
45
50
55
EP 2 281 051 B1
56
5
10
15
20
25
30
35
40
45
50
55
EP 2 281 051 B1
57
5
10
15
20
25
30
35
40
45
50
55
<210> 15
<211> 903
<212> DNA
<213> Ostreococcus tauri
<400> 15
<210> 16
<211> 300
<212> PRT
<213> Ostreococcus tauri
<400> 16
EP 2 281 051 B1
58
5
10
15
20
25
30
35
40
45
50
55
EP 2 281 051 B1
59
5
10
15
20
25
30
35
40
45
50
55
<210> 17
<211> 1560
<212> DNA
<213> Thraustochytrium ssp.
<400> 17
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<210> 18
<211> 519
<212> PRT
<213> Thraustochytrium ssp.
<400> 18
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<210> 19
<211> 31
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 19
gcggccgcgc catggtggac ctcaagcctg g 31
<210> 20
<211> 27
<212> DNA
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<213> Artificial
<220>
<223> Primer
<400> 20
gcggccgtta catcgctggg aactcgg 27
<210> 21
<211> 33
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 21
gcggccgcgc catgtcattg gctgctaaag atg 33
<210> 22
<211> 28
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 22
gcggccgtca atgacctgta actctaac 28
<210> 23
<211> 31
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 23
gcggccgcgc catggcgacg aaggaggcgt a 31
<210> 24
<211> 31
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 24
gcggccgcgt tacgtggact tggtcttggc c 31
<210> 25
<211> 32
<212> DNA
<213> Artificial
<220>
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<223> Primer
<400> 25
gcggccgcgc catggaggtc gtggagagat tc 32
<210> 26
<211> 28
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 26
gcggccgcgt cactcagttt tagctccc 28
<210> 27
<211> 30
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 27
gcggccgcca tggcgatcct gaacccggag 30
<210> 28
<211> 30
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 28
gcggccgctt agagcttgtt cttgtagaag 30
<210> 29
<211> 29
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 29
gcggccgcca tggccgtttc ttccggtgc 29
<210> 30
<211> 30
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 30
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gcggccgcct aaatcttttt ggaaggaaag 30
<210> 31
<211> 32
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 31
gcggccgcgc catgagcgcc tccggtgcgc tg 32
<210> 32
<211> 23
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 32
gcggccgcgt tagtcaattt ttc 23
<210> 33
<211> 32
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 33
gcggccgcgc catgacggtc ggctacgacg ag 32
<210> 34
<211> 29
<212> DNA
<213> Artificial
<220>
<223> Primer
<400> 34
gcggccgcgt caggcagcgc gctgccagg 29
<210> 35
<211> 26755
<212> DNA
<213> Artificial
<220>
<223> Plasmid
<400> 35
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Claims
1. A polynucleotide comprising a nucleic acid sequence selected from the group consisting of:
(a) nucleic acid sequence as shown in SEQ ID NO. 1;
(b) nucleic acid sequence which codes for a polypeptide having an amino acid sequence as shown in SEQ ID
NO. 2;
(c) nucleic acid sequence which hybridizes to a nucleic acid of (a) or (b) under stringent hybridization conditions,
wherein stringent hybridization conditions are hybridizations in 6 x sodium chloride/sodium citrate (SSC) at
approximately 45 °C, followed by one or more wash steps in 0.2 x SSC, 0.1 % SDS at 50 to 65 °C and wherein
the nucleic acid sequence codes for a polypeptide with Δ5 desaturase activity and acyl CoA specificity.
2. The polynucleotide according to claim 1, wherein the polynucleotide consists of RNA or DNA.
3. A vector comprising the polynucleotide according to claim 1 or 2.
4. The vector according to claim 3, wherein the vector is an expression vector.
5. The vector according to claim 3 or 4, wherein the vector comprises at least one further polynucleotide which codes
for a further enzyme which is involved in the biosynthesis of lipids or fatty acids.
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6. A host cell comprising the polynucleotide according to claim 1 or 2 or the vector according to any of claims 3 to 5.
7. The host cell according to claim 6, wherein the host cell additionally comprises at least one further enzyme which
is involved in the biosynthesis of lipids or fatty acids.
8. The vector according to claim 5 or the host cell according to claim 7, wherein the enzyme is selected from the group
consisting of: acyl-CoA dehydrogenase(s), acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s),
fatty acid acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s), fatty acid hydrox-
ylase(s), acetyl-coenzyme A carboxylase(s), acylcoenzyme A oxidase(s), fatty acid desaturase(s), fatty acid acet-
ylenase(s), lipoxygenase(s), triacylglycerol lipase(s), allene oxide synthase(s), hydroperoxide lyase(s), fatty acid
elongase(s), Δ4-desaturase(s), Δ5-desaturase(s), Δ6-desaturase(s), Δ8-desaturase(s), Δ9-desaturase(s), Δ12-de-
saturase(s), Δ5-elongase(s), Δ6-elongase(s) and Δ9-elongase(s).
9. A method of generating a polypeptide with desaturase activity, comprising the steps:
(a) expressing a polynucleotide according to claim 1 or 2 in a host cell; and
(b) obtaining, from the host cell, the polypeptide which is encoded by the polynucleotide according to (a).
10. A polypeptide which is encoded by the polynucleotide according to claim 1 or 2.
11. An antibody which specifically recognizes the polypeptide having an amino acid sequence as shown in SEQ ID NO. 2.
12. A transgenic, nonhuman organism comprising the polynucleotide according to claim 1 or 2, the vector according to
any of claims 3 to 5 or the host cell according to claim 8.
13. The transgenic, nonhuman organism according to claim 12, wherein the organism is an animal, a plant or a multi-
cellular microorganism.
14. A method for the production of a substance which has the structure shown in the general formula I hereinbelow
where the variables and substituents are as follows:
R1 = hydroxyl, coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphati-
dylglycerol, lysodiphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol, sphingo base or a rad-
ical of the formula II
R2 = hydrogen, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysodiphos-
phatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol or saturated or unsaturated C2-C24-alkylcar-
bonyl,
R3 = hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl, or R2 and R3 independently of one another are
a radical of the formula la:
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n = 2, 3, 4, 5, 6, 7 or 9, m = 2, 3, 4, 5 or 6 and p = 0 or 3;
and
wherein the method comprises the cultivation of (i) a host cell according to any of claims 3 to 5 or (ii) of a transgenic,
nonhuman organism according to claim 12 or 13 under conditions which permit the biosynthesis of the substance.
15. A method for the production of an oil, lipid or fatty acid composition, comprising the steps of the method according
to claim 14 and the further step of formulating the substance as an oil, lipid or fatty acid composition.
16. The method according to claim 15, wherein the oil, lipid or fatty acid composition is formulated further to give a drug,
a cosmetic product, a foodstuff, a feedstuff, preferably fish food, or a food supplement.
17. The use of the polynucleotide according to claim 1 or 2, of the vector according to any of claims 3 to 5, of the host
cell according to claim 6 or 7, of the vector or the host cell according to claim 8, of the polypeptide according to
claim 10 or of the transgenic, nonhuman organism according to claim 12 or 13 for the production of an oil, lipid or
fatty acid composition.
18. The use according to claim 17, wherein the oil, lipid or fatty acid composition is to be employed as a drug, cosmetic
product, foodstuff, feedstuff, preferably fish food, or food supplement.
Patentansprüche
1. Polynukleotid, umfassend eine Nukleinsäuresequenz, ausgewählt aus der Gruppe bestehend aus:
(a) Nukleinsäuresequenz gemäß SEQ ID NO. 1;
(b) Nukleinsäuresequenz, die für ein Polypeptid mit einer Aminosäuresequenz gemäß SEQ ID NO. 2 codiert;
(c) Nukleinsäuresequenz, die unter stringenten Hybridisierungsbedingungen mit einer Nukleinsäure gemäß (a)
oder (b) hybridisiert, wobei stringente Hybridisierungsbedingungen Hybridisierungen in 6 x Natriumchlorid/Na-
triumcitrat (SSC) bei ungefähr 45°C, gefolgt von einem oder mehreren Waschschritten in 0,2 x SSC, 0,1% SDS
bei 50 bis 65°C sind und wobei die Nukleinsäuresequenz für ein Polypeptid mit Δ5-Desaturaseaktivität und
Acyl-CoA-Spezifität codiert.
2. Polynukleotid nach Anspruch 1, wobei das Polynukleotid aus RNA oder DNA besteht.
3. Vektor, umfassend das Polynukleotid nach Anspruch 1 oder 2.
4. Vektor nach Anspruch 3, wobei der Vektor ein Expressionsvektor ist.
5. Vektor nach Anspruch 3 oder 4, wobei der Vektor mindestens ein weiteres Polynukleotid umfasst, das für ein weiteres
Enzym codiert, das an der Biosynthese von Lipiden oder Fettsäuren beteiligt ist.
6. Wirtszelle, umfassend das Polynukleotid nach Anspruch 1 oder 2 oder den Vektor nach einem der Ansprüche 3 bis 5.
7. Wirtszelle nach Anspruch 6, wobei die Wirtszelle zusätzlich mindestens ein weiteres Enzym umfasst, das an der
Biosynthese von Lipiden oder Fettsäuren beteiligt ist.
8. Vektor nach Anspruch 5 oder Wirtszelle nach Anspruch 7, wobei das Enzym aus der Gruppe bestehend aus: Acyl-
CoA-Dehydrogenase(n), Acyl-ACP[= Acyl Carrier Protein]-Desaturase(n), Acyl-ACP-Thioesterase(n), Fettsäurea-
cyltransferase(n), Acyl-CoA:Lysophospholipidacyltransferase(n), Fettsäuresynthase(n), Fettsäurehydroxylase(n),
Acetyl-Coenzym-A-Carboxylase(n), Acyl-Coenzym-A-Oxidase(n), Fettsäuredesaturase(n), Fettsäureacetylena-
se(n), Lipoxygenase(n), Triacylglycerollipase(n), Allenoxidsynthase(n), Hydroperoxidlyase(n), Fettsäureelonga-
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se(n), Δ4-Desaturase(n), Δ5-Desaturase(n), Δ-Desaturase(n), Δ8-Desaturase(n), Δ9-Desaturase(n), Δ12-Desatu-
rase(n), Δ5-Elongase(n), Δ6-Elongase(n) und Δ9-Elongase(n) ausgewählt ist.
9. Verfahren zur Herstellung eines Polypeptids mit Desaturaseaktivität, umfassend die Schritte:
(a) Exprimieren eines Polynukleotids nach Anspruch 1 oder 2 in einer Wirtszelle; und
(b) Gewinnen des Polypeptids, das von dem Polynukleotid gemäß (a) codiert wird, aus der Wirtszelle.
10. Polypeptid, das von dem Polynukleotid nach Anspruch 1 oder 2 codiert wird.
11. Antikörper der spezifisch das Polypeptid mit einer Aminosäuresequenz gemäß SEQ ID NO. 2 erkennt.
12. Transgener, nichtmenschlicher Organismus, umfassend das Polynukleotid nach Anspruch 1 oder 2, den Vektor
nach einem der Ansprüche 3 bis 5 oder die Wirtszelle nach Anspruch 8.
13. Transgener, nichtmenschlicher Organismus nach Anspruch 12, wobei es sich bei dem Organismus um ein Tier,
eine Pflanze oder einen mehrzelligen Mikroorganismus handelt.
14. Verfahren zur Herstellung einer Substanz mit der Struktur gemäß der allgemeinen Formel I unten
worin die Variablen und Substituenten folgendermaßen sind:
R1 = Hydroxyl, Coenzym A (Thioester), Lysophosphatidylcholin, Lysophosphatidylethanolamin, Lysophospha-
tidylglycerol, Lysodiphosphatidylglycerol, Lysophosphatidylserin, Lysophosphatidylinositol, Sphingobase oder
ein Rest der Formel II
R2 = Wasserstoff, Lysophosphatidylcholin, Lysophosphatidylethanolamin, Lysophosphatidylglycerol, Lysodi-
phosphatidylglycerol, Lysophosphatidylserin, Lysophosphatidylinositol oder gesättigtes oder ungesättigtes
C2-C24-Alkylcarbonyl,
R3 = Wasserstoff, gesättigtes oder ungesättigtes C2-C24-Alkylcarbonyl, oder R2 und R3 sind unabhängig von-
einander ein Rest der Formel Ia:
n = 2, 3, 4, 5, 6, 7 oder 9, m = 2, 3, 4, 5 oder 6 und p = 0 oder 3;
und
wobei das Verfahren das Kultivieren von (i) einer Wirtszelle nach einem der Ansprüche 3 bis 5 oder (ii) eines
transgenen, nichtmenschlichen Organismus nach Anspruch 12 oder 13 unter Bedingungen, die die Biosynthese
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der Substanz gestatten, umfasst.
15. Verfahren zur Herstellung einer Öl-, Lipid- oder Fettsäurezusammensetzung, umfassend die Schritte des Verfahrens
nach Anspruch 14 und den weiteren Schritt des Formulierens der Substanz als Öl-, Lipid- oder Fettsäurezusam-
mensetzung.
16. Verfahren nach Anspruch 15, wobei die Öl-, Lipid- oder Fettsäurezusammensetzung zu einem Arzneistoff, einem
Kosmetikprodukt, einem Nahrungsmittel, einem Futtermittel, vorzugsweise Fischfutter, oder einem Nahrungsergän-
zungsmittel weiterformuliert wird.
17. Verwendung des Polynukleotids nach Anspruch 1 oder 2, des Vektors nach einem der Ansprüche 3 bis 5, der
Wirtszelle nach Anspruch 6 oder 7, des Vektors oder der Wirtszelle nach Anspruch 8, des Polypeptids nach Anspruch
10 oder des transgenen, nichtmenschlichen Organismus nach Anspruch 12 oder 13 für die Herstellung einer Öl-,
Lipid- oder Fettsäurezusammensetzung.
18. Verwendung nach Anspruch 17, wobei die Öl-, Lipid- oder Fettsäurezusammensetzung als Arzneistoff, Kosmetik-
produkt, Nahrungsmittel, Futtermittel, vorzugsweise Fischfutter, oder Nahrungsergänzungsmittel zu verwenden ist.
Revendications
1. Polynucléotide comprenant une séquence d’acide nucléique choisie dans le groupe constitué de :
(a) une séquence d’acide nucléique telle que décrite dans SEQ ID NO. 1 ;
(b) une séquence d’acide nucléique qui code pour un polypeptide ayant une séquence d’acides aminés telle
que décrite dans SEQ ID NO. 2 ;
(c) une séquence d’acide nucléique qui s’hybride avec un acide nucléique de (a) ou (b) dans des conditions
d’hybridation stringentes, des conditions d’hybridation stringentes étant des hybridations dans 6 x chlorure de
sodium/citrate de sodium (SSC) à approximativement 45 °C, suivies d’une ou plusieurs étapes de lavage dans
0,2 x SSC, 0,1 % SDS à 50 à 65 °C et la séquence d’acide nucléique codant pour un polypeptide ayant une
activité Δ5 désaturase et une spécificité pour l’acyl-CoA.
2. Polynucléotide selon la revendication 1, le polynucléotide étant constitué d’ARN ou d’ADN.
3. Vecteur comprenant le polynucléotide selon la revendication 1 ou 2.
4. Vecteur selon la revendication 3, le vecteur étant un vecteur d’expression.
5. Vecteur selon la revendication 3 ou 4, le vecteur comprenant au moins un autre polynucléotide qui code pour une
autre enzyme qui est impliquée dans la biosynthèse des lipides ou des acides gras.
6. Cellule hôte comprenant le polynucléotide selon la revendication 1 ou 2 ou le vecteur selon l’une quelconque des
revendications 3 à 5.
7. Cellule hôte selon la revendication 6, la cellule hôte comprenant en outre au moins une autre enzyme qui est
impliquée dans la biosynthèse des lipides des acides gras.
8. Vecteur selon la revendication 5 ou cellule hôte selon la revendication 7, l’enzyme étant choisie dans le groupe
constitué des : acyl-CoA déshydrogénase(s), acyl-ACP [= protéine de transport d’acyle] désaturase(s), acyl-ACP
thioestérase(s), acide gras acyltransférase(s), acyl-CoA:lysophospholipide acyltransférase(s), acide gras syntha-
se(s), acide gras hydroxylase(s), acétyl-coenzyme A carboxylase(s), acylcoenzyme A oxydase(s), acide gras dé-
saturase(s), acide gras acétylénase(s), lipoxygénase(s), triacylglycérol lipase(s), oxyde d’allène synthase(s), hy-
droperoxyde lyase(s), acide gras élongase(s), Δ-désaturase(s), Δ5-désaturase(s), Δ6-désaturase(s), Δ8-désatura-
se(s), Δ9-désaturase(s), Δ12-désaturase(s), Δ5-élongase(s), Δ6-élongase(s) et Δ9-élongase(s).
9. Procédé de génération d’un polypeptide ayant une activité désaturase, comprenant les étapes de :
(a) expression d’un polynucléotide selon la revendication 1 ou 2 dans une cellule hôte ; et
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(b) obtention, à partir de la cellule hôte, du polypeptide qui est codé par le polynucléotide selon (a).
10. Polypeptide qui est codé par le polynucléotide selon la revendication 1 ou 2.
11. Anticorps qui reconnaît spécifiquement le polypeptide ayant une séquence d’acides aminés telle que décrite dans
SEQ ID NO. 2.
12. Organisme transgénique, non humain comprenant le polynucléotide selon la revendication 1 ou 2, le vecteur selon
l’une quelconque des revendications 3 à 5 ou la cellule hôte selon la revendication 8.
13. Organisme transgénique, non humain selon la revendication 12, l’organisme étant un animal, une plante ou un
micro-organisme multicellulaire.
14. Procédé de production d’une substance qui a la structure décrite dans la formule générale I ci-dessous
les variables et substituants étant comme suit :
R1 = hydroxyle, coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidyléthanolamine, lysophospha-
tidylglycérol, lysodiphosphatidylglycérol, lysophosphatidylsérine, lysophosphatidylinositol, sphingobase ou un
radical de formule II
R2 = hydrogène, lysophosphatidylcholine, lysophosphatidyléthanolamine, lysophosphatidylglycérol, lysodi-
phosphatidylglycérol, lysophosphatidylsérine, lysophosphatidylinositol ou alkylcarbonyle en C2-C24 saturé ou
insaturé,
R3 = hydrogène, alkylcarbonyle en C2-C24 saturé ou insaturé, ou R2 et R3 indépendamment l’un de l’autre sont
un radical de formule Ia :
n = 2, 3, 4, 5, 6, 7 ou 9, m = 2, 3, 4, 5 ou 6 et p = 0 ou 3 ;
et
le procédé comprenant la culture de (i) une cellule hôte selon l’une quelconque des revendications 3 à 5 ou (ii) un
organisme transgénique non humain selon la revendication 12 ou 13 dans des conditions qui permettent la biosyn-
thèse de la substance.
15. Procédé de production d’une composition d’huile, de lipide ou d’acide gras, comprenant les étapes du procédé
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selon la revendication 14 et l’étape supplémentaire de formulation de la substance sous la forme d’une composition
d’huile, de lipide ou d’acide gras.
16. Procédé selon la revendication 15, dans lequel la composition d’huile, de lipide ou d’acide gras est en outre formulée
pour obtenir un médicament, un produit cosmétique, un aliment pour humains, un aliment pour animaux, de préfé-
rence un aliment pour poissons, ou un supplément alimentaire.
17. Utilisation du polynucléotide selon la revendication 1 ou 2, du vecteur selon l’une quelconque des revendications
3 à 5, de la cellule hôte selon la revendication 6 ou 7, du vecteur ou de la cellule hôte selon la revendication 8, du
polypeptide selon la revendication 10 ou de l’organisme transgénique non humain selon la revendication 12 ou 13
pour la production d’une composition d’huile, de lipide ou d’acide gras.
18. Utilisation selon la revendication 17, dans laquelle la composition d’huile, de lipide ou d’acide gras est destinée à
être utilisé en tant que médicament, produit cosmétique, aliment pour humains, aliment pour animaux, de préférence
un aliment pour poissons, ou supplément alimentaire.
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